rfhg_136462.1

Basic information about the TSS

---

TSS ID: rfhg_136462.1 TSS ID(Version3): hg_114132.1 hg_114133.1 hg_114134.1 Species: human Chr: chr11		Start: 46381645 End: 46381751 Strand: +
Source datasets	FANTOM5|PRJNA615891|PRJNA548673|PRJNA4843412|DRA013844 |PRJNA401781|PRJNA597322|PRJDB5282
Protocol	CAGE|TIF-seq2|ReCappable-seq|SLIC_CAGE|NETCAGE |oligo_capping|STRIPE-seq|C1CAGE|RAMPAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS (EH38D2449289,EH38E1537407)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000617138.4:0 ENST00000395566.9:0 ENST00000395569.8:0 ENST00000533283.5:0 ENST00000481047.1:0 ENST00000395565.5:0 ENST00000489525.5:0 DQ323890:0 DQ323888:0 DQ323889:0 BC011704:0 X55110:0 GeneID: 4192 HGNC/MGI_ID: HGNC:6972 UniProt_ID: A0A087WXB6 E9PLM6 P21741 Q2LEK2 Q2LEK3 Nearer transcript ids and distances: ENST00000407067.1:2 LF348091:-216 MA583668:-216 LF348090:307 MA583667:307 DQ896549:307 KJ891598:307 DQ893220:307 M69148:307 ENST00000533952.5:-438 view more...

Gene_name: midkine Gene_symbol: MDK Gene_synonyms: FLJ27379 MK Gene_source: HGNC:6972

TATA-Box annotation

---

Distance to TSS:	-13
Nearest PromoterID:	NM_001012333
Entrez ID:	4192
Nearest Unigene:	Hs.82045
Nearest Refseq:	NM_002391
Nearest Ensembl:	ENSG00000110492
Gene Name:	midkine
Gene Alias:	ARAP|MK|NEGF2
Gene Type:	protein-coding
CpG%:	0.141509
GC%:	0.775701
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MDK p2@MDK p3@MDK p4@MDK p5@MDK p6@MDK p7@MDK p8@MDK p9@MDK p10@MDK
Sample		p1@MDK	p2@MDK	p3@MDK	p4@MDK	p5@MDK	p6@MDK	p7@MDK	p8@MDK	p9@MDK	p10@MDK
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.06	12.66	7.60	15.97	1.95	3.12	1.95	0.58	0.58	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.81	14.97	8.09	16.79	3.03	2.23	3.03	0.00	0.61	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	34.92	14.27	9.07	12.54	2.70	2.31	2.51	0.39	1.93	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.56	10.81	6.65	13.51	3.53	2.70	2.08	0.62	0.62	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.32	13.72	6.52	11.02	2.25	2.70	2.02	0.67	1.35	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.43	10.08	8.72	12.40	3.10	3.10	1.16	0.00	1.74	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.69	16.12	6.75	12.42	6.32	2.40	2.61	0.22	1.53	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	34.40	8.24	6.30	13.32	5.33	1.94	1.45	0.24	1.94	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.14	14.32	6.63	17.10	2.99	1.92	3.42	0.00	1.71	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.29	12.17	2.90	11.59	4.64	1.16	1.74	0.00	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.57	10.11	4.45	12.94	6.06	1.62	2.43	0.00	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.42	9.76	4.07	15.45	3.66	1.63	1.63	0.00	2.03	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.16	1.45	0.48	0.81	0.81	0.00	0.00	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.26	0.75	0.15	0.75	0.15	0.00	0.15	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.27	0.66	0.22	1.10	0.66	0.00	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.78	0.50	0.50	0.25	0.50	0.00	0.00	0.00	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.15	0.66	0.22	0.00	0.00	0.00	0.00	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.06	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1.07	0.00	0.00	0.53	2.13	0.00	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.81	0.45	0.15	0.45	0.75	0.00	0.15	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.01	0.94	0.27	0.13	1.07	0.13	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.39	0.52	0.00	0.35	1.04	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.69	1.29	0.39	0.13	0.52	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	3.15	0.97	0.00	0.24	0.49	0.00	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.71	1.03	1.03	0.26	0.77	0.00	0.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	5.06	0.63	0.00	0.63	0.32	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.40	0.55	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	5.42	1.65	0.00	0.00	0.71	0.24	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	3.55	0.97	0.00	0.00	0.97	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	3.62	1.63	0.54	0.54	0.36	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	3.35	0.42	0.21	0.00	0.63	0.00	0.00	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.47	1.95	0.20	0.20	0.59	0.20	0.20	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	5.49	1.06	0.21	0.42	0.84	0.00	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	5.61	1.65	0.49	0.16	0.49	0.33	0.00	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.92	0.93	0.19	0.37	0.93	0.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	0.96	0.19	0.57	0.77	0.00	0.00	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	5.52	1.23	0.61	0.41	0.20	0.00	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.05	0.81	0.00	0.40	0.60	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	3.24	0.81	0.00	0.54	1.08	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	4.32	0.48	0.72	0.48	0.72	0.00	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.47	0.71	0.00	0.71	0.71	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	3.95	1.02	0.00	0.15	1.02	0.00	0.00	0.29	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	3.80	1.69	0.00	0.42	0.42	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.85	0.52	0.52	0.35	0.35	0.00	0.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	4.42	1.20	0.00	0.20	0.20	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	5.82	0.93	0.47	0.00	0.23	0.00	0.00	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.32	1.20	0.24	0.24	0.72	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.96	1.19	0.00	0.30	0.89	0.00	0.00	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	2.87	0.72	0.24	0.24	0.72	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.05	1.21	0.20	0.20	0.61	0.00	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	3.69	0.20	0.20	0.00	0.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5.34	0.00	0.00	0.44	0.67	0.00	0.00	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2.48	0.35	0.35	0.00	1.06	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.63	0.66	0.00	1.33	0.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	0.84	0.00	0.00	0.84	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.05	0.46	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	3.89	0.32	0.65	0.00	0.65	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	3.21	0.64	0.00	0.32	0.96	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	4.71	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.94	1.41	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.80	0.00	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	0.00	0.80	0.00	0.80	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	2.72	0.00	0.00	1.02	0.34	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1.62	0.32	0.32	0.00	0.65	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1.42	1.06	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	1.46	0.98	0.00	0.00	0.00	0.00	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	1.98	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.35	0.00	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	0.93	0.31	0.00	0.00	0.62	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	0.92	0.31	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	2.38	0.48	1.74	0.32	0.00	0.00	0.00	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	0.96	0.16	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	1.53	0.38	1.91	0.13	0.51	0.00	0.00	0.00	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	2.99	1.49	0.75	0.75	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	3.35	0.67	0.00	0.67	0.33	0.00	0.00	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	0.00	0.00	0.00	0.64	0.64	0.00	0.00	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	0.00	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	2.26	4.06	0.90	0.90	1.81	0.00	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	5.91	1.39	1.74	0.87	0.52	0.70	0.00	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	80.58	22.49	9.00	5.87	4.50	1.76	0.00	0.39	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	90.60	13.90	12.61	6.18	6.69	1.54	0.26	0.51	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	51.57	7.81	10.04	3.90	6.97	0.56	0.00	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	47.61	5.88	4.70	2.35	4.70	0.59	0.59	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	29.76	8.12	5.47	2.01	1.21	0.56	0.32	0.08	0.08	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	46.15	9.04	11.30	3.55	3.23	2.58	0.00	0.00	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	3.73	2.67	1.07	3.73	1.07	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	5.56	1.11	1.67	1.67	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	3.33	2.08	0.83	0.00	0.00	0.42	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.83	3.27	4.77	1.00	1.00	0.25	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	20.29	1.64	5.56	0.65	1.64	0.98	0.33	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	3.65	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	50.61	17.68	7.51	7.73	8.84	0.66	0.88	1.33	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	55.22	32.63	7.17	15.78	6.45	1.08	3.23	1.08	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	58.70	15.57	10.78	7.19	19.17	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	54.51	23.21	59.91	13.13	6.66	1.08	1.08	2.34	1.08	3.06
Amniotic Epithelial Cells, donor2	11613-122A2	110.45	41.84	100.41	21.76	8.37	0.00	0.00	1.67	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	76.84	30.00	62.46	16.02	9.45	1.03	2.67	4.73	1.64	1.23
Anulus Pulposus Cell, donor1	11248-116E6	76.89	17.85	8.47	5.26	6.87	0.92	0.57	1.03	0.57	0.46
Anulus Pulposus Cell, donor2	11463-119B5	29.63	9.55	4.90	2.94	4.16	1.22	0.00	0.24	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	39.54	6.29	6.74	3.15	7.19	1.35	0.45	0.90	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.93	9.12	9.99	3.47	9.99	0.87	0.87	1.30	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	4.28	10.70	2.14	4.28	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	43.34	5.38	6.88	5.38	7.17	0.90	0.30	0.90	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	54.38	16.44	12.65	6.32	7.59	3.79	0.00	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	7.26	7.26	3.30	7.92	0.00	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	33.46	7.15	8.45	5.52	5.52	1.95	0.00	1.30	0.32	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	54.85	8.25	9.22	4.37	8.74	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.23	5.34	6.53	2.38	6.53	1.78	0.59	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	43.69	10.17	7.16	4.14	8.29	1.88	1.13	0.75	1.13	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	34.11	8.71	9.43	2.18	7.26	0.00	1.45	0.00	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	43.88	3.76	6.27	8.78	8.78	1.25	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	50.24	10.38	11.53	5.11	9.39	0.99	0.49	1.65	0.33	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	50.50	4.09	9.55	6.82	8.19	1.36	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.84	9.20	6.63	4.22	4.83	0.45	0.30	0.60	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	36.97	4.29	8.04	4.29	5.36	0.54	0.54	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	39.68	11.15	7.75	4.72	4.91	0.57	0.38	1.32	0.94	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	31.81	6.15	9.89	1.87	5.08	0.53	1.07	0.53	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	39.99	5.85	8.78	3.90	7.80	0.98	0.00	0.00	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	41.80	13.60	7.63	4.98	7.80	0.66	0.50	0.66	1.00	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	30.02	3.60	6.00	4.80	7.20	0.00	0.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	17.70	7.08	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	38.25	14.58	9.09	5.32	5.83	1.03	0.51	1.20	0.86	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	8.39	4.19	4.19	12.58	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	44.17	8.25	9.22	4.37	7.28	1.46	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	53.50	15.18	15.18	4.55	8.73	1.90	0.76	0.76	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	6.06	8.48	3.63	3.63	1.21	1.21	1.21	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	47.31	13.11	10.83	6.84	6.27	0.00	0.57	0.57	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	43.61	7.70	11.76	4.70	6.84	0.43	1.07	1.50	0.64	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.78	4.13	8.26	5.16	5.68	1.29	0.52	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	45.04	10.79	9.85	3.75	8.45	0.47	1.41	1.41	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	39.87	12.86	4.82	6.11	9.32	0.96	0.32	0.64	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	36.39	3.57	6.42	2.14	9.99	0.00	0.71	1.43	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.76	13.45	7.60	2.92	7.02	0.58	0.00	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	38.54	6.62	9.63	6.02	4.82	1.81	0.60	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	27.32	3.56	8.32	2.38	7.13	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	57.98	9.15	7.63	4.58	7.12	2.03	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	41.26	11.46	7.39	5.09	6.11	1.02	0.76	0.51	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	36.22	5.08	8.90	3.81	5.72	0.00	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	41.00	10.36	10.79	6.47	3.88	2.59	0.00	1.29	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	38.10	9.53	4.45	6.14	6.99	1.06	0.64	1.06	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	29.58	4.64	3.77	3.19	7.25	0.58	0.58	1.45	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	49.13	6.61	10.39	2.83	6.61	0.94	2.83	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	41.03	11.53	6.27	6.44	5.59	1.02	0.68	0.51	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	6.95	6.95	4.63	0.00	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	4.23	8.45	0.00	4.23	0.00	2.11	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	40.52	10.08	7.08	4.72	5.57	1.93	0.43	1.29	1.29	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	27.07	3.61	5.41	4.21	9.02	0.60	0.00	1.20	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.80	8.02	7.29	5.10	7.29	0.00	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	47.82	13.10	9.20	4.83	7.36	0.69	0.23	1.84	1.38	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	48.46	7.65	7.65	7.65	5.10	2.55	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.88	3.81	4.32	5.08	4.32	0.76	0.51	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	44.80	10.32	9.70	7.64	9.29	1.65	0.62	0.21	0.00	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	36.11	7.04	7.34	4.59	6.43	0.61	0.61	0.31	0.92	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	46.85	4.78	5.74	4.30	5.74	1.43	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.70	9.98	6.65	5.10	5.99	0.44	0.22	0.22	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	6.10	7.63	1.53	6.10	0.00	3.05	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	34.89	6.09	7.75	2.22	6.65	1.11	0.55	1.66	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	39.19	9.53	8.74	3.71	3.71	1.06	0.26	0.79	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	34.89	6.18	7.63	3.27	6.91	1.09	0.36	1.45	0.73	0.73
Astrocyte - cerebellum, donor1	11500-119F6	125.76	48.51	56.99	51.21	27.88	6.26	5.28	1.72	1.60	2.46
Astrocyte - cerebellum, donor2	11580-120F5	114.16	54.26	26.70	23.45	13.18	3.42	2.23	2.23	1.71	1.20
Astrocyte - cerebellum, donor3	11661-122F5	187.09	72.99	43.84	43.84	14.47	5.24	3.15	1.47	0.63	3.36
Astrocyte - cerebral cortex, donor1	11235-116D2	208.45	110.50	64.14	113.99	15.34	5.93	14.64	2.79	3.49	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	165.01	85.90	33.49	73.77	11.00	5.01	7.77	1.94	0.81	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	163.18	104.56	39.53	83.83	11.34	3.58	8.05	1.64	1.49	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2.41	0.23	1.26	0.23	0.00	0.92	0.00	0.00	0.23	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1.38	0.38	1.38	0.00	0.00	0.75	0.00	0.13	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.96	0.23	0.68	0.23	0.00	0.91	0.00	0.00	0.11	0.11
Basophils, donor1	12241-129G9	0.00	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	0.00	0.00	0.00	0.00	0.00	0.36	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	3.09	1.03	1.47	0.15	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	12.29	7.33	2.59	3.02	2.59	0.22	0.22	0.65	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	18.74	9.60	1.83	5.03	4.11	0.46	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1.26	1.88	0.63	0.00	1.88	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.99	2.08	0.62	0.62	0.21	0.00	0.21	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	4.61	1.61	0.92	1.61	0.46	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	13.68	3.78	0.72	1.62	1.26	0.00	0.18	0.36	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	53.40	8.31	9.91	2.24	5.76	2.88	0.32	2.56	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	10.34	10.34	20.68	0.00	0.00	0.00	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	0.00	0.00	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1.42	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.24	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.00	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.00	0.00	0.25	0.25	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.00	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	0.00	0.00	0.00	0.00	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	0.82	0.41	0.41	0.82	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	18.07	1.00	7.03	1.00	1.00	0.00	0.00	5.02	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	8.43	1.12	3.37	1.12	1.12	0.00	0.00	1.69	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.79	4.13	3.76	2.25	1.50	0.75	0.00	2.25	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	22.77	2.93	3.61	0.68	2.03	0.45	0.00	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.33	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	1.79	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	0.00	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	15.83	2.75	7.57	2.06	2.06	2.98	0.46	1.15	0.23	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.73	2.40	6.71	0.24	3.12	5.75	0.00	0.24	0.00	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.14	1.64	4.65	2.46	1.09	2.74	0.00	0.55	0.27	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.21	6.00	7.51	1.80	2.10	4.50	0.00	0.00	0.30	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	17.52	3.36	8.64	1.92	2.40	6.24	0.00	0.48	0.48	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.60	4.32	7.28	2.27	1.59	5.91	0.00	0.45	0.23	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.82	2.82	8.04	3.69	2.39	4.35	0.00	0.22	0.00	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.06	1.32	6.84	1.58	1.58	3.16	0.53	0.00	0.26	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.53	1.88	8.68	1.41	1.64	5.63	0.23	0.70	0.70	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.89	0.91	8.45	2.42	2.42	4.53	0.30	0.91	0.30	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.11	1.45	7.26	1.16	1.74	4.07	0.00	0.87	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.52	2.13	7.73	3.46	1.87	5.86	0.27	1.07	0.27	2.13
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.32	3.06	8.32	0.88	1.75	7.88	0.00	0.00	0.00	5.25
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.20	0.46	10.47	0.46	0.46	9.56	0.00	0.00	0.00	5.01
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	0.75	7.46	1.49	0.75	14.92	0.00	0.00	0.00	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.77	4.68	12.97	3.60	3.60	6.84	0.00	0.72	0.00	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.98	4.89	7.19	2.01	2.01	6.62	0.00	1.15	0.29	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.26	4.24	7.07	2.36	2.59	7.31	0.47	0.94	0.00	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.55	2.85	6.34	2.85	2.22	2.85	0.32	1.58	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.84	3.38	7.69	1.85	2.15	2.15	0.31	0.92	0.31	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.07	1.28	8.66	1.28	3.21	2.24	0.00	1.60	0.64	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.00	3.06	4.97	1.15	2.29	5.35	0.00	0.38	0.00	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.82	1.18	8.28	1.58	1.18	1.58	0.39	0.79	0.00	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.81	1.51	5.29	3.78	3.03	1.51	0.00	1.51	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	6.42	1.61	5.62	0.00	0.80	5.62	0.80	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	4.20	0.70	0.70	0.00	5.60	0.00	0.00	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	4.01	3.01	6.01	0.00	0.00	9.02	0.00	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	124.29	12.79	34.73	3.66	14.62	5.48	0.00	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	113.15	37.06	38.04	14.82	11.36	6.42	0.99	2.47	2.47	0.99
Cardiac Myocyte, donor3	11686-122I3	53.88	24.41	19.68	7.26	7.26	0.42	0.53	0.74	0.53	0.53
Chondrocyte - de diff, donor1	11261-116G1	12.13	5.20	4.16	2.77	2.08	1.04	0.69	0.00	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	19.19	7.82	7.11	3.20	2.13	0.71	0.36	1.42	0.71	0.71
Chondrocyte - de diff, donor3	11410-118E6	26.17	5.35	6.26	3.30	2.16	0.91	0.46	0.57	0.68	0.91
Chondrocyte - re diff, donor2	11339-117F7	24.17	7.16	1.79	0.90	1.79	1.79	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	23.05	6.07	3.24	1.21	1.62	2.43	0.00	0.00	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	271.98	95.02	68.97	64.72	34.54	10.56	7.23	2.41	4.36	5.74
Ciliary Epithelial Cells, donor2	11323-117D9	207.14	69.47	34.63	30.57	28.43	4.06	3.63	1.07	2.78	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	207.70	103.63	42.30	38.94	23.54	4.25	4.25	2.30	4.34	1.95
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.39	8.16	23.93	3.21	2.48	1.65	0.37	0.18	0.55	0.46
Corneal Epithelial Cells, donor1	11526-119I5	18.66	8.34	2.42	3.73	2.20	0.22	0.00	0.88	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	1.14	0.00	2.28	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.95	5.37	1.53	2.30	1.02	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.00	0.00	0.50	0.00	0.00	0.33	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.63	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.54	0.22	0.11	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	45.69	18.01	6.00	7.34	6.67	0.50	1.33	0.67	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	24.06	10.56	4.11	2.93	3.52	1.17	0.59	1.76	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	37.05	10.46	5.94	4.81	7.64	0.28	0.00	0.57	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	28.70	8.26	3.15	4.72	9.44	0.00	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	50.32	16.87	5.24	9.60	9.02	1.45	1.16	0.29	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	69.41	32.47	8.00	9.88	14.35	0.24	1.18	0.94	0.94	0.00
Endothelial Cells - Artery, donor3	11413-118E9	36.81	17.36	4.21	6.14	6.66	1.05	0.18	0.35	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	55.19	15.29	8.64	4.21	7.31	0.66	0.22	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.77	21.91	3.96	4.26	18.86	0.91	1.22	0.91	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	56.66	16.07	7.33	5.64	9.58	0.85	0.00	2.26	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	62.40	27.93	11.89	13.07	19.31	2.97	2.08	1.19	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	64.04	19.26	3.64	6.25	13.02	1.04	0.52	1.04	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	132.85	56.86	16.87	14.60	18.43	2.41	1.84	3.40	0.43	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	21.21	6.80	3.60	4.40	6.40	0.80	0.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	83.86	33.54	11.53	18.34	20.44	0.52	1.05	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	89.95	25.22	9.32	8.20	11.68	1.49	0.87	1.12	0.25	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	84.08	20.42	6.30	6.52	12.38	0.87	0.87	1.09	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	74.01	24.79	5.13	5.37	7.21	0.61	0.49	0.61	0.61	0.12
Endothelial Cells - Vein, donor1	11267-116G7	54.60	27.30	0.00	10.24	11.38	0.00	1.14	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	29.34	5.59	3.49	4.19	8.38	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	81.80	33.76	4.71	9.42	10.21	0.31	1.41	0.16	0.63	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.80	5.13	1.22	2.20	3.18	0.24	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	5.75	2.05	2.05	0.00	0.00	0.41	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.12	1.75	1.09	1.31	1.75	0.44	0.22	0.11	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.43	2.38	1.73	4.44	0.76	0.33	1.08	0.43	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	23.41	6.31	4.00	4.49	2.43	0.24	0.73	0.00	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.41	3.00	2.46	0.55	1.91	0.14	0.00	0.00	0.14	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.32	8.75	7.17	2.95	5.91	1.16	0.32	0.53	0.74	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	31.62	17.92	21.61	8.70	11.07	1.05	0.00	0.79	0.79	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	36.87	11.96	6.98	7.31	2.99	0.33	1.00	1.00	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	32.21	7.71	7.26	5.44	3.18	0.91	0.00	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	15.16	2.27	2.27	2.27	5.31	0.76	0.00	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	9.31	3.94	1.73	1.10	1.10	0.00	0.00	0.00	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	30.01	13.34	19.40	2.73	3.33	0.30	0.30	0.91	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	21.32	6.47	4.31	3.17	3.68	0.13	0.25	0.63	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	16.37	4.40	3.79	2.73	1.36	0.30	0.15	0.15	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.13	4.42	4.82	3.75	5.76	0.54	0.00	0.54	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.81	4.75	6.04	1.29	4.31	0.43	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	87.89	35.16	19.04	7.32	10.25	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	80.26	20.53	10.84	10.15	7.61	2.77	0.92	1.15	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	51.90	12.21	10.69	2.71	8.14	0.68	0.17	0.34	0.68	0.68
Fibroblast - Dermal, donor1	11269-116G9	6.57	0.94	0.70	0.23	0.70	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	5.66	2.36	2.36	1.42	2.36	0.00	0.00	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	6.04	1.45	1.09	0.85	0.85	0.48	0.00	0.00	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	20.12	7.12	4.86	2.37	1.81	0.11	0.23	0.23	0.00	0.45
Fibroblast - Dermal, donor5	11454-119A5	11.86	3.66	2.27	1.57	1.22	0.17	0.17	0.00	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	15.92	4.22	2.76	1.62	1.95	0.32	0.49	0.32	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	7.50	1.04	0.62	0.21	0.42	0.00	0.42	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	80.70	17.29	23.06	5.24	6.81	8.65	0.79	1.05	1.31	2.36
Fibroblast - Gingival, donor2	11318-117D4	46.12	13.31	6.72	3.56	4.22	1.98	0.53	0.40	0.00	0.66
Fibroblast - Gingival, donor3	11394-118C8	13.05	3.19	2.22	1.06	0.29	0.48	0.00	0.00	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	136.09	59.22	34.28	9.35	9.35	8.31	1.04	0.00	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	96.03	25.90	13.74	5.11	5.64	4.58	0.88	0.53	0.35	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.94	6.55	5.77	2.03	3.12	1.40	0.47	0.31	0.47	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.63	2.98	2.16	1.76	1.62	0.81	0.00	0.41	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.11	7.06	7.41	1.41	2.47	1.76	0.71	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.67	3.95	4.39	2.05	1.46	1.61	0.29	0.15	0.29	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.23	2.59	5.05	1.50	2.86	1.91	0.27	0.55	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.36	5.48	4.17	1.76	1.65	1.10	0.11	0.22	0.22	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	153.05	29.20	23.18	11.30	11.45	5.43	0.73	0.73	0.44	2.20
Fibroblast - Lung, donor1	11270-116H1	38.06	13.59	9.52	8.16	6.80	0.00	0.00	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	5.97	2.98	4.48	0.00	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	82.52	24.06	11.61	5.28	5.06	2.11	0.21	1.48	0.84	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	3.33	4.17	0.00	0.83	1.67	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	2.80	2.80	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.23	0.84	2.80	1.12	0.84	0.84	0.00	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	7.71	1.62	3.25	2.03	1.22	0.81	0.41	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	5.96	0.00	5.96	0.00	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.12	10.28	4.85	2.91	2.33	0.78	0.19	0.00	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.49	19.72	8.04	3.03	2.58	1.52	0.00	0.30	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	4.90	1.22	0.92	0.61	0.92	0.31	0.31	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	43.51	10.69	5.34	7.63	3.82	1.91	0.38	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	24.84	7.29	2.97	1.35	0.54	1.35	0.27	0.81	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	77.93	27.95	13.92	4.75	3.60	3.25	0.46	0.81	0.46	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	24.98	10.61	5.75	4.20	2.98	0.77	0.44	0.22	0.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.57	5.49	12.60	2.44	3.25	0.61	0.41	1.22	0.00	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	4.01	4.01	3.34	1.34	2.67	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.47	2.37	5.14	1.58	1.98	0.40	0.00	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	8.93	4.17	8.53	1.79	2.38	1.59	0.20	0.20	0.20	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.27	9.77	23.62	3.55	5.15	3.20	0.36	1.24	1.24	2.49
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.79	5.12	7.49	2.17	4.73	3.15	0.20	0.79	0.99	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.45	8.12	12.03	2.41	4.51	2.11	0.00	0.30	0.30	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	36.16	8.53	12.85	4.75	5.51	1.94	0.65	1.30	1.19	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.09	3.29	3.54	2.02	2.78	1.27	0.00	0.00	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	25.76	7.55	7.88	4.59	3.28	1.80	0.33	1.64	1.31	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.45	9.42	9.22	2.21	3.81	0.40	0.00	0.80	0.60	1.00
Fibroblast - skin normal, donor2	11561-120D4	24.21	5.22	5.73	3.11	3.52	1.11	0.20	1.41	0.40	1.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.07	3.32	7.86	1.21	3.93	1.21	0.00	0.91	0.00	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	53.19	9.20	26.43	4.72	9.44	2.73	0.41	0.75	1.08	1.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	44.28	10.43	23.59	5.30	9.74	5.47	0.34	1.88	0.68	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	10.84	20.36	1.97	6.24	0.99	0.00	0.66	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	28.65	8.52	8.20	5.54	6.28	0.96	0.43	0.43	0.85	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	40.48	14.84	6.58	6.92	2.70	1.35	0.84	0.51	0.84	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.76	4.70	5.80	2.82	1.57	0.63	0.47	0.63	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	3.49	0.00	0.87	0.87	0.87	0.00	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.55	0.69	0.69	0.87	0.17	0.35	0.00	0.00	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	3.90	0.78	0.52	0.78	0.78	0.00	0.26	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	3.58	2.81	0.77	1.02	1.02	0.26	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	141.63	36.75	29.09	58.18	30.62	3.83	7.66	1.53	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	116.13	24.88	31.27	51.68	29.35	9.57	9.57	2.55	1.91	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	172.30	57.34	11.41	47.07	21.68	1.14	6.28	0.86	0.57	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	273.00	146.70	12.41	156.91	10.48	3.31	15.44	0.55	0.83	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	152.98	105.03	31.97	149.55	13.47	10.05	21.23	1.14	0.68	4.11
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	181.88	91.93	15.45	67.17	17.24	4.76	7.53	0.79	0.59	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	254.03	132.17	15.86	135.87	10.04	5.29	16.12	0.00	1.59	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	154.92	150.03	55.44	183.95	14.68	10.44	31.64	0.98	0.65	5.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	110.11	42.01	13.27	37.59	19.90	1.33	6.63	0.00	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	228.24	82.53	48.33	77.44	33.21	9.19	13.57	0.99	0.42	3.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	201.58	76.10	30.05	66.50	19.70	6.40	8.25	0.86	1.35	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	201.74	77.90	36.00	69.57	38.41	9.13	8.06	0.54	1.61	4.57
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	179.15	65.42	28.62	39.65	18.46	5.33	5.70	0.74	1.86	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	169.43	53.99	21.32	43.60	16.20	4.57	5.12	0.42	0.55	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	122.59	41.68	25.62	29.07	22.16	5.29	4.27	0.81	0.41	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	217.00	72.56	26.47	35.60	26.47	3.65	6.39	1.83	1.60	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	175.39	46.34	17.81	27.78	13.95	3.36	3.24	0.75	0.62	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	155.63	53.55	12.46	21.42	19.67	2.40	4.37	0.00	0.44	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	271.25	113.76	45.50	51.12	23.34	6.50	8.86	0.89	0.89	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	196.79	72.01	24.96	55.32	18.76	6.36	7.15	0.48	1.43	3.81
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	222.53	94.51	49.15	40.44	22.12	6.93	3.57	1.34	1.79	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	190.75	74.00	35.49	42.14	15.32	8.67	4.03	1.01	1.01	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	182.70	60.39	27.82	50.04	14.25	8.14	7.46	0.51	1.87	4.24
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	171.94	59.32	26.34	35.82	23.68	6.65	6.74	0.80	0.98	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	268.88	86.78	67.12	35.90	24.04	8.32	3.64	1.56	2.08	1.87
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	212.79	61.14	54.48	42.52	25.62	8.54	4.27	2.05	1.71	4.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	156.13	62.52	24.34	35.63	11.07	4.76	3.87	0.55	0.89	2.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	160.07	53.00	26.79	35.52	18.80	4.41	6.41	0.75	1.33	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	123.53	42.06	26.34	40.22	16.74	6.13	4.49	1.02	2.04	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	181.14	74.48	31.77	31.15	13.82	4.33	4.33	0.41	0.83	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	176.28	57.30	25.94	30.67	11.30	4.96	5.65	0.81	1.15	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	151.92	65.37	21.35	23.68	11.51	5.17	3.00	0.83	0.83	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	145.93	47.17	23.15	20.72	11.02	2.42	1.76	0.44	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	140.21	47.60	19.19	22.63	10.45	4.18	3.20	0.61	0.61	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	149.61	62.08	23.34	33.88	12.81	9.56	4.54	0.97	1.46	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	127.00	40.41	21.81	17.64	11.87	3.85	1.60	0.32	1.28	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	94.56	29.94	13.83	15.07	9.19	3.13	1.71	0.28	0.47	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	90.79	28.47	10.12	10.44	7.28	3.01	1.90	0.32	0.79	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	72.68	19.77	13.68	11.25	8.82	2.43	0.61	0.61	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	81.64	23.83	11.81	11.29	8.15	1.46	1.57	0.52	0.84	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	66.96	23.27	9.66	11.42	6.37	1.98	0.88	0.88	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	51.06	12.62	10.38	8.42	9.26	2.24	2.24	0.84	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	52.03	13.43	4.91	8.15	4.17	0.74	0.93	0.28	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.32	13.37	6.15	6.69	4.81	2.14	1.60	0.00	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	47.43	9.79	5.66	3.98	6.73	0.15	0.77	0.46	0.31	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	31.61	8.42	4.40	6.48	4.53	0.65	0.65	0.26	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	36.05	17.35	8.95	6.23	3.25	0.81	0.81	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	43.88	10.14	8.11	3.69	7.56	0.92	0.74	0.55	0.37	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	40.57	10.97	9.43	3.95	4.82	0.44	0.66	0.22	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	62.48	16.86	14.88	8.93	11.90	0.99	0.99	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	26.65	6.73	8.18	2.37	2.77	0.92	0.13	0.00	0.66	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.44	7.06	6.86	2.02	4.04	1.61	0.20	0.00	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	82.35	27.45	36.60	9.15	11.18	2.54	0.76	1.27	0.25	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	145.91	70.67	30.85	71.66	39.61	9.95	13.14	0.80	0.80	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	212.63	69.49	27.43	71.65	28.20	10.94	9.55	0.46	0.31	3.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	253.48	83.27	29.66	89.40	31.91	12.27	13.91	1.02	1.02	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	191.51	81.05	22.84	119.54	48.82	4.07	17.21	1.25	0.31	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	178.01	66.97	16.67	113.59	48.88	3.39	19.21	0.57	1.13	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	121.76	47.04	12.91	84.86	27.67	1.84	9.69	0.00	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	190.56	64.34	17.32	116.32	37.12	4.95	14.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	175.22	69.24	20.11	109.08	37.91	5.42	15.47	1.55	1.55	3.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	121.94	52.95	40.11	80.22	44.93	3.21	14.44	1.60	1.60	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	231.26	119.98	17.39	113.02	46.95	6.96	13.91	0.00	1.74	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	220.35	83.00	35.80	93.74	28.97	5.86	11.07	0.65	1.63	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	188.19	83.18	49.42	83.18	30.47	6.59	8.24	0.82	0.82	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	193.27	106.63	26.66	79.97	23.33	6.66	19.99	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	248.05	110.46	75.50	94.80	22.37	5.31	12.02	1.68	1.40	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	250.04	106.22	71.58	100.34	31.70	5.23	12.09	1.96	0.33	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	296.11	135.89	60.40	95.63	26.00	4.19	6.71	0.00	3.36	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	353.06	140.27	130.41	97.01	26.40	7.00	9.54	1.59	2.23	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	295.51	112.09	102.58	81.86	27.85	8.49	12.57	1.36	1.36	6.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	409.28	108.58	85.61	104.41	25.06	2.09	18.79	2.09	2.09	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	461.02	159.78	186.70	120.84	21.76	6.87	12.60	0.57	1.15	6.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	384.19	163.68	170.49	81.99	19.24	7.10	10.66	2.07	1.18	7.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	404.90	211.77	243.96	98.26	6.78	6.78	20.33	1.69	5.08	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	475.10	192.61	344.21	121.36	32.31	12.01	16.98	4.56	3.31	9.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	451.97	187.56	243.25	143.14	33.14	13.12	20.94	3.45	3.22	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	384.60	205.47	226.55	57.95	10.54	5.27	10.54	5.27	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	319.45	152.61	239.87	107.64	13.45	6.92	14.61	2.31	1.92	10.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	377.80	160.70	273.16	90.29	17.60	5.87	13.04	3.91	1.30	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	364.52	153.83	178.58	60.20	16.05	4.01	6.02	1.34	1.34	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	497.38	189.17	258.51	92.85	9.63	8.48	13.48	3.47	2.31	8.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	379.65	152.68	233.48	90.38	16.09	8.90	10.27	2.74	3.08	6.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	385.14	181.39	178.90	52.18	12.42	2.48	2.48	0.00	0.00	12.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	310.95	141.08	129.29	64.17	5.19	4.72	6.13	1.89	0.47	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	385.63	151.48	193.12	70.01	8.45	6.64	7.24	2.41	0.00	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	370.82	178.04	185.67	80.88	6.10	4.58	8.14	2.03	2.03	7.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	448.69	188.25	197.03	88.94	9.17	4.39	10.77	3.19	1.60	3.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	374.46	158.86	211.65	60.68	9.37	2.96	7.89	0.00	1.48	8.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	344.69	114.50	108.60	46.04	4.72	3.54	16.53	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	385.07	151.11	183.20	75.26	7.00	5.83	7.00	4.08	1.17	8.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	360.76	123.76	152.73	42.13	7.02	2.19	3.07	1.32	1.32	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	299.24	105.96	122.92	47.47	4.24	3.39	3.39	0.00	1.70	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	315.77	102.67	240.56	59.09	8.95	2.98	7.16	2.98	2.39	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	325.60	128.11	242.62	84.43	20.87	7.28	16.98	3.40	3.88	10.19
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	1.14	5.71	1.14	0.00	5.71	0.00	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.24	1.25	4.16	0.83	1.25	0.83	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	2.25	1.12	1.12	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.64	3.17	11.73	1.90	0.95	2.85	0.32	0.95	0.95	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.63	6.68	7.10	2.92	0.42	0.84	0.00	0.42	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.11	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.00	0.00	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	0.00	0.12	0.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.17	0.00	0.34	0.17	0.00	0.00	0.00	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	61.00	24.62	10.63	12.31	12.87	3.36	2.24	1.12	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	100.41	24.24	14.28	12.98	12.12	2.16	2.16	0.87	1.30	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	5.29	10.58	7.93	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	124.16	59.61	64.90	18.34	11.99	1.06	2.12	3.17	0.71	2.82
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	168.55	51.58	97.35	15.26	13.80	2.18	2.18	0.00	3.63	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	58.05	35.49	11.54	13.11	4.20	0.35	1.05	1.75	0.70	0.70
Hepatocyte, donor1	11523-119I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	2.15	0.00	1.08	0.00	0.00	0.00	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	3.07	0.61	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.65	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	95.96	55.41	11.01	17.30	9.09	1.92	1.75	0.87	0.35	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	103.45	39.79	13.72	12.07	18.93	1.10	1.10	0.69	0.82	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	127.36	31.84	9.55	25.47	9.55	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	153.53	33.38	0.00	40.05	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	98.29	44.30	11.08	22.15	4.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	115.12	50.05	10.01	25.03	12.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	35.60	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	115.33	28.19	7.69	10.25	12.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	137.12	27.42	13.71	22.85	0.00	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	112.08	37.36	11.37	22.74	4.87	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	116.71	33.35	8.34	8.34	8.34	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	87.13	21.78	3.63	14.52	10.89	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	100.58	38.38	13.23	18.53	6.62	1.32	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	115.30	38.80	9.98	19.96	7.76	0.00	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	52.38	20.95	0.00	10.48	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	110.23	36.53	18.90	12.60	6.30	0.63	1.26	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	114.45	49.49	17.01	13.92	12.37	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	14.63	14.63	0.00	14.63	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	129.21	40.70	14.21	21.32	9.04	0.65	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	133.62	41.86	16.10	17.71	4.83	0.00	1.61	0.00	0.00	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	59.74	0.00	11.95	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	132.83	27.71	22.82	20.37	2.44	0.81	2.44	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	121.33	42.40	20.99	21.41	8.82	0.00	2.10	1.26	0.84	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	107.69	30.54	12.86	13.66	5.63	0.00	4.82	0.80	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	102.48	43.39	9.23	16.62	5.54	0.00	1.85	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	30.16	15.08	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	151.05	32.57	23.13	25.49	4.25	0.47	1.42	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	124.26	43.54	14.51	9.07	5.44	0.00	2.72	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	121.60	26.90	12.91	16.14	6.46	0.00	4.30	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	120.69	40.65	19.06	20.33	5.08	0.00	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00	16.43	16.43	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	82.90	24.87	14.67	17.22	7.65	0.64	1.28	0.64	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	102.07	32.81	9.11	14.58	9.11	0.00	0.00	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	31.61	0.00	0.00	0.00	0.00	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	107.11	32.13	15.00	13.57	12.14	0.71	0.71	0.71	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	39.82	6.64	23.23	9.95	0.00	0.00	0.00	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	137.35	39.51	15.43	26.85	8.03	0.62	0.93	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	89.56	33.36	24.58	14.05	7.02	1.76	1.76	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	22.00	28.29	9.43	9.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	95.27	31.99	16.69	11.82	8.34	1.39	0.70	1.39	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	119.51	30.98	15.49	22.13	2.21	2.21	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	94.02	19.45	25.94	16.21	6.48	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	117.71	35.75	16.57	18.31	9.59	0.00	0.87	0.00	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	130.49	53.99	33.75	18.00	9.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	76.66	34.85	6.97	10.45	3.48	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	131.21	48.00	19.20	16.00	6.40	0.00	2.13	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	116.38	60.96	13.85	15.24	4.16	1.39	4.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	96.89	51.29	11.40	5.70	8.55	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	151.87	36.82	14.73	26.69	6.44	0.92	0.00	1.84	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	102.86	42.35	18.15	33.28	0.00	0.00	3.03	0.00	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	93.13	24.83	24.83	6.21	12.42	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	107.85	27.49	14.80	27.49	4.23	0.00	2.11	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	2.37	0.33	0.08	0.16	0.65	0.00	0.00	0.00	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	0.59	1.17	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	3.22	0.47	0.00	0.76	0.85	0.00	0.09	0.00	0.00	0.09
Keratinocyte - oral, donor1	11251-116E9	37.91	14.53	1.70	4.99	3.75	0.23	0.23	0.57	0.57	0.11
Keratocytes, donor1	11527-119I6	125.15	41.60	18.22	15.47	8.94	3.44	1.38	0.34	0.00	0.69
Keratocytes, donor2	11607-120I5	5.86	4.69	0.00	1.17	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	103.94	35.37	15.02	9.68	7.11	4.74	0.79	0.40	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	2.20	8.79	13.19	4.40	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	105.72	32.36	17.26	12.94	15.10	2.16	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	330.43	196.76	61.24	134.02	59.74	10.73	13.15	2.42	2.08	3.92
Lens Epithelial Cells, donor3	11690-122I7	92.63	35.62	18.26	9.28	19.88	0.81	0.91	2.02	2.02	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	132.21	50.51	16.96	18.62	20.40	3.32	1.42	1.90	1.07	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	95.72	29.86	11.16	9.21	17.58	4.19	0.84	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	123.10	32.27	15.27	12.28	16.37	3.78	1.10	2.99	0.94	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	102.70	32.26	10.75	15.06	19.90	1.61	2.15	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	82.26	25.84	15.76	5.99	14.50	1.58	0.63	2.21	0.32	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	123.77	31.16	16.60	11.75	16.39	2.16	1.51	2.26	0.32	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	103.42	23.39	11.08	15.59	18.88	2.87	1.23	0.41	1.64	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	128.43	34.89	19.21	13.91	15.67	2.53	1.77	1.77	0.25	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	116.68	30.12	13.23	12.81	16.75	2.39	1.55	1.83	0.42	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	90.97	18.99	12.26	11.87	15.82	1.98	1.19	3.16	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	122.15	31.80	18.03	11.83	14.54	2.91	0.58	1.16	1.55	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	130.90	34.44	14.26	15.92	19.44	3.52	1.48	1.67	0.93	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	114.28	25.78	13.24	13.24	23.69	2.09	2.09	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	135.24	25.28	16.46	12.16	17.17	3.34	0.95	1.67	0.24	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	119.63	32.83	15.11	14.97	13.87	2.75	1.10	3.30	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	109.02	25.56	15.40	12.63	18.79	3.08	1.85	1.85	0.31	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	118.15	29.93	15.28	14.03	11.85	3.12	1.56	1.87	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	138.52	35.68	18.30	15.55	20.68	3.48	1.46	2.01	1.10	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	113.21	26.66	13.82	10.20	15.80	2.30	0.66	3.62	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	123.01	23.14	13.18	11.13	16.99	3.22	0.59	1.17	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	126.46	27.13	15.18	12.94	21.16	3.49	0.50	2.99	1.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	90.69	22.79	15.52	13.09	13.09	2.42	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	105.03	30.16	14.00	12.39	16.16	2.69	1.62	1.35	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	128.37	32.85	16.35	11.20	18.17	3.78	0.76	2.42	1.51	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	90.20	17.11	16.07	10.37	12.96	2.07	0.52	1.04	1.56	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	103.65	26.38	14.66	9.21	14.66	3.14	0.84	2.30	1.88	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	130.37	30.83	18.50	14.13	18.35	3.31	2.11	1.20	1.20	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	94.24	17.88	15.13	12.38	18.57	1.38	0.69	1.38	0.69	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	108.19	27.66	13.73	11.48	13.55	3.01	0.19	2.26	0.94	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	144.52	41.56	20.25	17.81	18.13	3.71	1.59	2.33	1.06	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	107.09	26.65	11.63	20.35	14.05	1.94	2.42	1.94	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	111.15	24.81	14.22	8.93	14.22	3.31	1.65	1.98	1.32	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	138.02	39.65	17.96	15.36	18.83	3.96	1.98	2.48	0.74	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	94.03	23.69	17.03	13.70	18.88	2.22	1.85	0.37	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	99.82	20.26	13.84	8.40	15.32	1.73	0.49	1.73	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	130.21	38.50	18.42	14.99	16.09	4.40	1.65	1.65	1.51	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	108.39	28.30	17.69	11.90	19.94	1.93	1.61	2.25	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	104.08	20.39	13.69	8.22	14.00	3.04	0.91	1.52	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	127.09	35.55	17.36	12.60	15.26	2.94	0.98	1.96	1.12	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	117.69	28.80	11.73	22.04	18.84	2.49	2.13	1.42	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	79.50	17.94	15.51	11.15	14.54	1.45	0.00	1.94	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	145.49	33.46	21.32	14.16	19.61	6.07	1.24	2.80	2.02	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	112.80	29.72	14.32	15.04	17.55	2.86	1.79	2.15	1.07	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	97.68	28.09	15.68	11.76	16.99	3.27	1.63	1.63	0.33	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	132.78	26.13	17.89	17.19	17.89	5.18	1.88	1.88	1.18	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	122.76	46.16	15.47	15.84	19.92	3.34	1.98	1.73	1.61	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	126.53	32.27	13.57	13.06	17.93	2.56	2.05	0.77	1.54	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	131.28	37.59	18.20	20.88	16.71	4.77	1.79	1.79	1.19	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	20.39	2.27	0.00	0.00	2.27	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	37.59	17.64	0.77	5.37	0.77	2.30	0.00	0.77	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	36.37	13.36	8.16	8.16	0.74	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.46	9.73	6.35	5.08	2.12	2.54	0.42	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	38.68	19.69	6.33	11.25	1.41	3.52	0.70	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	16.81	4.67	8.41	1.87	1.87	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	9.79	6.18	4.64	1.55	3.09	1.03	0.00	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	33.30	11.89	3.57	2.38	3.57	3.57	1.19	0.00	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.71	21.04	9.95	6.33	1.36	1.58	0.00	0.90	2.49	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.76	11.34	4.07	5.53	1.45	1.16	0.29	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	12.15	6.75	6.75	1.80	1.35	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.68	15.58	8.67	5.83	2.17	2.71	0.54	0.27	2.17	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.35	8.22	2.57	3.08	0.51	2.05	1.54	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	34.93	15.17	4.59	7.41	0.71	2.47	0.35	0.71	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.99	6.66	9.99	8.00	0.67	2.00	0.00	0.67	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	26.49	8.15	6.11	3.06	1.02	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	34.42	15.21	8.54	6.67	1.87	2.13	0.53	0.80	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	36.28	13.23	4.53	6.42	0.76	1.70	0.94	0.76	1.51	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.16	9.82	4.91	3.68	1.23	2.45	0.61	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	27.72	21.20	7.34	4.08	2.45	0.00	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.99	13.12	5.00	5.62	1.04	1.04	0.62	0.62	0.42	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.91	9.81	3.64	4.48	0.84	0.84	0.56	0.56	0.84	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	30.91	13.39	5.15	8.24	2.06	4.12	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	27.87	11.03	5.23	4.94	1.16	1.45	0.87	0.58	1.45	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.11	8.37	2.09	5.08	1.49	0.90	0.90	0.90	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	37.07	14.38	3.32	8.85	3.87	1.11	0.00	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.75	11.31	6.36	4.24	1.06	0.00	0.71	0.71	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	31.72	7.01	2.95	2.95	1.84	1.11	0.37	0.37	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	29.93	14.97	4.61	6.91	2.30	0.00	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	32.62	11.13	6.52	2.30	1.15	0.77	1.15	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.81	8.49	2.83	1.70	0.57	2.26	0.57	0.57	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	26.25	11.49	7.38	2.46	1.64	2.46	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.63	17.62	6.33	4.07	0.90	1.81	0.90	0.45	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	5.75	2.15	2.87	1.44	1.44	1.44	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	40.33	21.66	7.47	9.71	3.73	0.75	0.00	0.75	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.21	15.61	5.20	8.55	2.60	2.60	0.74	0.00	1.86	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	21.54	3.88	5.60	5.17	1.29	0.00	0.00	0.86	0.43	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	39.39	11.13	5.99	6.85	0.00	1.71	0.86	1.71	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	32.98	12.33	6.33	6.33	0.67	2.33	0.00	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	21.12	7.84	4.83	6.03	1.21	2.41	0.00	1.81	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	26.31	16.35	5.69	5.69	0.00	0.71	0.00	0.00	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	32.65	14.78	6.19	5.50	1.72	1.03	1.37	0.34	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.62	9.66	4.83	5.37	1.61	2.68	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	35.69	22.22	8.75	8.08	0.67	0.67	0.00	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.74	8.89	7.04	2.96	1.85	2.22	0.74	0.00	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	38.38	15.12	4.65	3.49	2.33	2.33	0.00	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	10.58	2.12	6.35	2.12	3.17	0.00	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.81	12.80	3.20	4.80	2.40	2.40	1.20	0.00	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	4.36	7.27	5.09	0.73	1.45	0.00	0.73	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	47.52	22.23	6.90	5.37	0.77	2.30	0.77	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	27.13	15.29	7.89	7.89	0.49	3.95	0.49	0.00	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.94	4.70	2.82	2.82	0.94	1.88	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.20	15.59	4.02	6.03	2.51	1.51	0.50	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.54	10.36	7.21	5.41	1.80	0.45	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	3.44	5.16	3.44	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	36.52	11.58	6.23	9.80	1.78	2.23	0.00	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	29.72	11.73	7.04	3.13	3.13	1.56	0.00	0.00	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	20.45	6.60	5.28	3.30	0.66	3.96	0.66	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	32.17	18.16	6.75	5.71	1.04	1.04	1.04	1.56	1.56	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	34.57	11.81	4.38	8.31	1.75	1.75	0.00	0.00	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	11.18	2.24	5.59	1.68	0.56	0.00	0.00	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.54	14.57	7.51	7.51	0.44	0.88	0.44	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.79	11.19	5.01	6.56	1.16	1.16	0.00	0.77	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	9.62	6.58	4.05	1.01	1.52	0.00	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	36.53	12.02	5.29	5.77	0.48	1.92	0.96	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.03	11.93	5.96	3.98	0.80	0.80	0.00	0.40	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	4.86	4.25	4.86	1.22	1.82	0.00	0.00	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.98	5.53	2.08	2.77	0.69	0.69	1.38	0.00	0.69	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.36	18.24	3.04	6.08	0.38	2.28	1.14	0.38	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.43	6.20	5.16	3.61	1.03	0.52	0.52	0.00	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	6.65	6.05	3.63	1.21	2.42	0.60	0.60	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	27.57	11.73	8.24	4.75	1.58	2.22	0.32	0.95	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.39	4.26	5.86	1.60	2.67	0.53	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.79	8.62	5.17	1.15	1.15	1.72	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	30.85	12.34	4.63	6.17	1.54	1.54	1.03	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.15	8.49	4.95	3.54	1.41	0.71	0.00	0.71	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.19	9.08	3.40	1.13	3.40	2.27	0.00	1.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	26.21	12.48	4.99	5.41	1.25	1.66	2.50	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	10.18	3.92	3.13	0.00	3.13	0.78	0.78	2.35	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.79	6.26	3.76	5.43	2.92	1.25	0.42	0.00	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	32.52	15.33	6.04	5.11	1.39	2.32	0.93	0.46	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	12.04	4.01	3.35	0.67	2.01	0.00	0.00	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.25	4.81	6.42	4.28	2.67	0.53	0.00	0.00	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.29	12.12	2.83	4.85	0.00	2.02	0.40	0.00	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	4.59	1.84	1.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	5.33	3.56	6.22	1.78	2.67	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	31.34	11.40	5.70	5.13	0.57	1.71	0.57	0.00	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	7.67	6.90	4.60	2.30	0.00	0.77	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.87	8.75	8.21	3.28	2.74	1.64	0.00	0.00	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.62	15.59	3.56	3.12	2.23	1.78	0.45	0.45	0.45	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	31.19	12.48	7.28	4.16	1.82	2.08	0.00	0.26	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.90	5.97	2.65	3.98	1.99	1.99	0.66	0.00	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	20.79	2.08	4.16	2.08	2.08	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	0.18	0.00	0.37	0.18	0.00	0.18	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.39	0.26	0.26	0.13	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1.06	0.53	0.00	0.53	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.13	1.74	1.27	2.69	1.43	0.32	0.16	0.32	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	3.75	2.36	0.83	0.69	1.67	0.00	0.14	0.42	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	1.30	0.40	0.00	0.40	0.30	0.10	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	1.74	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	1.50	0.75	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	1.36	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	1.41	0.11	0.11	0.22	0.00	0.11	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	8.02	1.49	1.19	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	5.85	0.68	0.45	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	1.60	0.89	0.53	0.18	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.55	0.00	0.33	0.00	0.00	0.11	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.46	0.11	0.11	0.11	0.00	0.11	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.00	0.00	0.00	0.17	0.00	0.17	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	93.73	26.67	14.73	7.66	11.04	1.69	0.40	2.29	0.80	0.70
Melanocyte - dark, donor2	11582-120F7	113.52	48.11	33.57	17.65	8.31	4.50	1.04	2.08	1.38	1.73
Melanocyte - dark, donor3	11663-122F7	7.32	2.03	1.52	0.14	0.22	0.00	0.07	0.14	0.07	0.00
Melanocyte - light, donor1	11274-116H5	2.59	0.24	1.18	0.24	0.24	0.47	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	3.41	1.36	3.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.01	3.47	0.87	0.00	0.87	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	3.12	0.52	0.73	0.10	0.10	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	2.96	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	16.34	1.61	4.29	0.80	1.07	0.27	0.54	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	17.62	3.97	6.95	2.85	5.09	0.74	0.74	0.37	0.37	0.37
Meningeal Cells, donor2	11573-120E7	61.18	20.25	11.44	5.28	13.64	1.32	0.00	0.88	4.84	0.44
Meningeal Cells, donor3	11654-122E7	12.55	2.45	3.02	0.82	1.22	0.00	0.33	0.24	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	104.94	40.78	10.55	13.40	6.56	1.14	1.71	0.57	0.86	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	51.22	10.67	10.67	1.61	13.69	0.91	0.40	0.81	0.70	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	59.14	10.51	22.34	5.26	3.94	7.88	0.00	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	0.00	1.31	0.00	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.94	2.87	2.87	0.72	0.72	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.99	12.92	20.54	6.56	6.56	0.85	0.85	1.06	1.06	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.09	7.54	9.05	2.01	4.02	0.50	0.00	0.50	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	77.79	21.54	13.19	9.89	7.91	2.20	1.32	0.88	0.66	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	56.99	19.00	2.92	8.04	4.38	1.46	0.73	1.46	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	56.67	19.23	5.12	6.75	5.12	1.23	0.00	0.82	0.61	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	69.95	27.56	14.13	13.44	29.92	2.91	1.66	1.39	0.97	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	100.74	26.76	247.94	10.78	9.66	2.23	1.49	1.49	1.12	5.20
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.45	17.24	104.60	5.53	4.47	0.92	0.26	1.45	0.79	1.45
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	127.89	62.32	346.00	20.18	28.49	3.86	1.78	2.67	2.08	7.12
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	102.76	37.37	210.20	11.68	2.34	2.34	0.00	2.34	0.00	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	89.66	31.38	29.46	10.89	6.40	1.28	1.28	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	11.70	1.42	2.48	1.42	3.54	0.35	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	57.23	30.33	86.94	5.00	5.63	1.56	0.31	0.31	0.63	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	64.59	26.12	13.06	6.53	3.63	2.90	0.73	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	28.11	9.81	5.04	3.18	10.34	0.27	0.53	0.80	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	60.56	21.52	11.51	5.00	31.03	0.50	3.00	2.00	2.00	1.00
Mesothelial Cells, donor3	11402-118D7	13.01	4.48	2.38	0.94	4.05	0.29	0.07	0.29	0.29	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	2.70	1.35	0.00	4.05	1.35	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	3.69	0.74	0.00	0.00	2.22	0.25	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.24	0.29	0.00	0.00	0.88	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	2.17	1.86	0.62	0.00	0.31	0.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.11	1.04	0.41	0.21	1.04	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2.75	2.25	0.50	0.25	1.75	0.25	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.72	1.40	0.00	0.00	1.40	0.00	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1.83	1.02	0.20	0.00	1.22	0.00	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.38	0.40	0.40	0.00	1.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	0.00	0.00	0.00	1.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.80	0.76	0.76	0.38	0.76	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	0.00	0.00	1.32	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.64	0.85	0.42	0.00	1.06	0.42	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.09	1.19	0.30	0.00	0.30	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.51	1.00	0.25	0.00	1.00	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.09	0.24	0.95	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	2.21	0.00	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.38	0.23	0.23	0.23	1.61	0.46	0.00	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.26	0.42	0.00	0.00	0.84	0.63	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.22	0.82	0.00	0.00	0.82	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.72	0.21	0.43	0.21	0.43	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	0.67	1.33	0.00	0.89	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.53	0.88	0.44	0.00	0.88	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.01	1.52	0.00	0.00	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.36	0.54	1.09	0.00	0.54	0.27	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.76	0.29	0.00	0.29	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	1.09	1.09	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.44	0.96	0.00	0.00	0.96	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.20	0.00	1.20	0.00	0.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	2.74	1.37	0.00	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	0.00	0.50	0.00	2.00	1.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.19	0.44	0.88	0.00	0.44	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	0.00	1.10	0.00	0.00	2.21	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	0.64	0.64	1.28	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.98	0.25	0.74	0.25	0.74	0.99	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	0.70	0.70	0.00	0.00	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	0.00	0.00	0.00	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.39	1.37	1.37	0.00	1.37	0.34	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	0.44	1.31	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.13	0.36	1.07	0.00	1.07	0.71	0.00	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1.96	1.96	1.68	0.00	0.28	0.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.08	0.83	1.25	0.42	0.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	0.58	0.58	0.00	0.58	1.75	0.00	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.81	1.21	0.90	0.00	1.21	1.51	0.00	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.67	0.00	2.09	0.42	0.83	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	0.00	2.77	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	2.28	3.41	0.00	0.57	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.87	1.38	2.63	0.00	0.41	1.52	0.00	0.14	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.11	1.04	2.59	0.26	1.81	1.30	0.00	0.52	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.86	2.14	2.57	0.00	0.00	2.14	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	0.64	1.27	0.64	0.00	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.74	0.80	2.94	0.00	1.87	2.40	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.39	1.20	3.89	0.00	1.20	1.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.12	0.71	1.27	0.00	0.71	0.99	0.00	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	0.32	3.19	0.00	0.96	0.96	0.00	0.32	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.30	3.10	3.32	0.22	0.88	1.77	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.79	0.38	2.28	0.00	0.38	4.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.41	1.99	2.84	0.00	0.85	1.70	0.00	0.00	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5.90	2.70	3.20	0.00	0.98	1.97	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.96	1.30	1.96	0.00	0.00	1.96	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.82	0.00	5.00	0.29	0.59	0.59	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.77	1.73	4.61	0.29	0.29	0.86	0.00	0.58	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.06	0.41	2.47	0.00	0.41	2.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4.17	1.49	5.36	0.30	0.00	2.38	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.80	0.00	0.53	0.00	0.00	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	13.05	0.00	3.26	9.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	9.50	0.00	0.00	28.51	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	16.59	3.66	2.80	1.29	0.86	0.00	0.43	0.43	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.58	9.93	9.41	6.27	1.05	1.05	0.52	1.05	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.03	4.67	6.01	2.67	4.67	0.67	0.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	9.18	0.00	2.09	2.92	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	41.45	7.99	1.14	2.09	1.90	0.57	0.00	1.14	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	98.94	6.38	14.36	1.60	1.60	1.60	1.60	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	4.08	2.04	0.68	2.04	0.00	0.68	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	66.16	11.03	3.68	3.68	3.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	36.83	9.63	3.77	5.86	3.35	2.09	1.67	0.00	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	36.96	8.14	2.79	1.16	4.42	0.93	0.70	0.00	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	38.37	12.70	5.13	2.43	2.97	0.81	0.00	0.27	0.81	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	80.73	14.30	11.77	6.10	7.57	1.68	0.42	0.84	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	44.54	0.00	0.00	33.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	58.57	9.43	7.45	2.98	7.94	1.99	0.00	0.00	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	64.42	10.83	3.52	3.79	5.14	1.35	0.27	0.27	0.54	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	40.58	12.69	5.44	2.95	8.39	1.36	0.68	0.23	1.36	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	37.07	7.35	4.41	1.96	4.57	0.65	0.33	0.33	0.33	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	98.42	15.13	16.95	6.01	9.11	3.28	0.18	0.36	0.36	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	43.50	11.67	5.30	1.59	4.24	1.06	0.53	0.53	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	54.63	13.81	9.60	3.60	11.41	3.00	0.00	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	80.40	9.52	4.27	2.63	9.52	2.63	0.00	0.98	0.33	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	41.31	9.76	5.04	2.60	8.13	1.30	0.16	0.33	0.81	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	113.06	19.58	25.22	5.47	12.52	4.41	0.18	0.71	1.06	3.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	42.19	10.55	9.14	2.81	7.03	1.41	0.70	0.70	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	67.58	13.33	9.65	3.22	13.33	2.76	0.00	0.46	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	59.13	17.03	9.00	2.89	5.78	1.61	1.29	0.64	0.64	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	78.98	10.69	8.28	1.03	12.76	0.34	0.00	0.34	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	227.56	25.28	22.76	2.53	10.11	0.00	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	90.00	16.93	19.83	2.90	8.24	2.45	0.45	0.22	0.22	2.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.45	5.93	2.54	1.27	3.81	1.69	0.00	0.42	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.39	11.16	6.88	1.19	8.54	1.66	0.24	0.47	0.95	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	51.51	18.03	6.87	1.72	4.29	0.86	0.86	0.43	0.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	198.61	18.06	18.06	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	34.66	14.00	9.33	1.33	4.67	0.67	0.00	1.33	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	64.47	5.86	12.62	2.25	8.12	2.71	0.00	0.45	0.45	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.84	4.76	4.76	2.78	3.57	0.40	0.00	0.79	1.59	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	2.79	10.22	0.93	5.57	0.93	1.86	0.00	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.84	11.73	7.57	4.54	2.65	0.00	1.14	0.38	0.38	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	5.87	5.87	1.63	3.26	0.00	0.33	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	37.48	13.07	8.28	1.31	3.49	0.87	0.87	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	72.37	10.85	11.31	1.36	8.14	1.36	0.45	0.45	1.36	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	7.94	4.41	1.76	2.65	0.88	0.00	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	9.31	7.31	1.99	4.65	3.99	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	55.56	21.33	4.96	1.98	7.44	0.99	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.97	11.10	2.68	0.77	1.53	0.77	0.38	0.38	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	55.35	11.49	5.44	1.21	6.35	0.91	0.30	0.30	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.90	7.74	8.18	3.54	5.53	1.77	1.11	0.22	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	5.42	2.71	2.71	2.71	0.00	1.36	0.68	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	15.33	25.55	0.00	15.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	49.38	11.58	6.71	1.22	6.10	3.66	1.22	1.22	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.88	6.92	4.09	3.15	2.52	0.63	0.63	0.00	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.84	6.05	4.24	0.00	2.12	0.61	0.00	0.30	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	15.03	3.96	1.58	7.91	3.96	0.00	1.58	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	52.15	4.53	5.67	3.40	3.40	0.00	0.00	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	5.06	5.06	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.10	0.75	0.75	0.50	0.37	0.00	0.00	0.00	0.12	0.12
Myoblast, donor2	11322-117D8	21.29	5.37	3.45	1.15	0.77	0.19	0.00	0.38	0.58	0.38
Myoblast, donor3	11398-118D3	15.64	5.72	2.35	1.85	0.84	0.17	0.67	0.17	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	93.28	30.12	43.19	42.46	19.96	2.18	4.72	1.81	1.45	0.73
Neural stem cells, donor2	11352-117H2	100.13	38.51	59.69	46.22	11.55	0.00	11.55	0.00	1.93	0.00
Neurons, donor1	11494-119E9	96.72	31.86	47.79	50.07	4.55	0.00	4.55	1.14	1.14	0.00
Neurons, donor2	11574-120E8	92.69	34.13	22.68	22.46	4.40	0.44	1.32	0.88	0.44	0.88
Neurons, donor3	11655-122E8	80.57	22.20	18.91	30.42	4.93	0.82	2.47	0.00	2.47	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	167.54	56.76	26.12	12.23	17.34	2.49	1.19	1.07	1.66	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	95.73	43.96	20.19	4.88	12.05	4.56	1.63	0.00	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	47.93	15.24	5.21	5.21	10.83	0.40	0.20	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	6.61	1.38	2.20	0.69	0.83	0.14	0.00	0.00	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	7.82	1.74	0.43	0.72	0.43	0.43	0.00	0.00	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	4.88	1.59	1.82	0.11	0.45	0.34	0.11	0.57	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	3.02	0.00	0.97	0.00	0.19	0.29	0.10	0.00	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	71.62	27.68	5.42	4.21	4.81	1.81	0.60	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	7.87	5.10	5.32	2.55	1.91	0.85	0.00	0.64	1.06	0.21
Osteoblast - differentiated, donor2	11353-117H3	58.30	22.86	16.00	9.14	10.29	3.43	2.29	3.43	3.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	27.31	15.52	9.93	4.34	3.10	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	149.70	46.12	20.13	20.91	16.61	1.17	2.15	2.93	1.37	0.59
Osteoblast, donor2	11354-117H4	73.74	26.69	10.53	21.07	9.83	0.00	2.11	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	61.49	29.15	10.13	8.53	6.93	0.71	0.89	0.89	1.42	1.07
Pancreatic stromal cells, donor1	11249-116E7	53.15	12.55	10.70	4.38	5.81	1.60	1.01	0.59	0.34	0.93
Pericytes, donor1	11491-119E6	48.73	13.80	13.69	6.56	11.79	1.78	0.33	0.67	0.78	0.45
Pericytes, donor2	11571-120E5	45.27	15.62	12.22	7.24	7.70	0.68	0.91	0.00	0.68	0.23
Pericytes, donor3	11652-122E5	26.45	3.87	6.10	2.64	1.42	0.81	0.20	0.00	0.61	0.20
Perineurial Cells, donor1	11499-119F5	43.85	14.13	7.57	4.86	6.78	0.68	0.68	0.68	0.68	0.23
Perineurial Cells, donor2	11579-120F4	151.36	59.44	45.36	19.23	12.33	3.40	2.02	1.84	1.20	2.39
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.13	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	30.61	15.55	14.83	6.22	3.11	0.24	0.24	0.48	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	73.19	33.27	74.30	22.18	13.31	3.33	2.22	7.76	0.00	5.54
Placental Epithelial Cells, donor3	11427-118G5	171.39	112.89	205.16	44.17	18.06	1.37	2.55	8.44	4.71	4.32
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.22	0.32	3.16	0.32	0.00	0.00	0.00	0.63	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	0.75	0.19	1.88	0.19	0.19	0.00	0.00	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	1.83	0.65	2.35	0.13	0.13	0.52	0.00	0.13	0.00	0.52
Preadipocyte - breast, donor2	11328-117E5	6.53	2.48	3.15	0.45	0.00	0.23	0.00	0.00	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	2.98	0.21	1.81	0.21	0.21	0.43	0.00	0.32	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	10.48	2.18	4.36	0.44	0.44	0.44	0.00	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	6.73	1.29	3.72	0.57	0.00	0.00	0.00	0.43	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.98	0.98	0.00	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.69	0.31	0.31	0.61	0.61	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	15.23	2.48	1.06	1.42	1.42	0.00	0.35	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	23.84	3.92	2.72	1.87	2.21	0.68	0.17	0.34	0.68	0.51
Preadipocyte - visceral, donor1	11280-116I2	16.58	3.17	2.98	1.12	1.96	0.19	0.19	0.65	0.00	0.09
Preadipocyte - visceral, donor2	11357-117H7	49.24	6.44	7.36	2.76	8.74	0.92	0.00	0.00	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	13.17	2.82	1.57	0.84	2.09	0.10	0.21	0.21	0.10	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	149.49	129.28	15.99	38.92	11.01	2.26	5.13	0.45	0.75	0.30
Prostate Epithelial Cells, donor2	11331-117E8	13.81	7.18	1.49	2.17	3.93	0.00	0.00	0.27	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	28.54	17.94	0.73	3.92	1.84	0.24	0.24	0.37	0.24	0.06
Prostate Stromal Cells, donor1	11254-116F3	51.71	14.12	10.02	5.24	4.90	0.91	0.57	0.46	0.80	0.11
Prostate Stromal Cells, donor2	11332-117E9	64.55	23.13	13.09	7.71	8.25	2.15	1.26	1.08	1.08	1.43
Prostate Stromal Cells, donor3	11405-118E1	89.26	37.54	14.08	9.38	12.72	2.50	1.15	1.46	0.94	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	139.42	48.18	22.26	18.25	14.23	3.28	1.82	2.19	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	54.48	11.64	6.45	4.71	9.01	0.83	0.28	1.04	0.42	0.07
Renal Epithelial Cells, donor1	11517-119H5	270.35	90.79	33.98	45.65	26.88	7.10	4.57	6.09	0.51	1.01
Renal Epithelial Cells, donor2	11597-120H4	177.83	41.97	15.65	21.34	17.07	1.42	2.85	2.85	2.13	0.71
Renal Epithelial Cells, donor3	11678-122H4	95.28	17.47	15.67	7.52	16.41	2.33	0.85	1.91	1.27	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	44.26	18.38	5.45	3.40	14.98	2.72	0.00	2.72	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	31.13	8.89	3.77	3.64	8.89	0.81	0.13	0.54	0.00	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	75.71	15.10	7.55	5.55	10.21	1.11	0.89	1.11	1.11	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	157.04	27.28	29.94	24.62	31.28	2.66	0.67	3.33	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	148.34	48.20	9.24	18.05	15.63	1.98	3.08	3.08	0.44	1.10
Renal Mesangial Cells, donor2	11598-120H5	144.21	43.89	17.56	16.93	17.56	2.51	2.51	5.02	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	229.97	60.20	19.70	12.48	22.75	3.61	1.39	2.77	0.83	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.38	5.91	6.17	1.34	4.29	0.81	0.00	1.07	0.54	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	7.17	2.11	2.53	3.37	0.42	0.00	0.42	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	167.97	42.62	23.72	19.48	15.62	2.12	1.93	1.93	1.35	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	252.80	100.60	36.56	21.52	22.56	3.11	3.11	1.81	2.85	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	211.19	51.73	38.94	22.74	29.85	4.26	1.42	3.98	4.26	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	226.41	73.07	39.11	38.08	24.70	6.17	3.09	2.06	3.09	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	65.99	13.30	15.05	12.80	15.81	1.25	1.00	0.25	2.76	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	6.68	2.81	6.15	0.27	0.53	0.27	0.00	0.40	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	34.84	5.36	46.46	0.00	0.00	6.25	0.00	0.00	1.79	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.26	1.65	42.93	0.55	1.65	4.95	0.00	0.55	0.00	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	35.38	2.32	49.30	4.06	1.16	8.70	0.00	1.74	1.16	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	23.27	5.59	35.37	2.86	2.08	2.99	0.26	2.99	1.69	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	49.85	8.04	34.56	3.28	1.39	3.48	0.20	0.99	1.59	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	44.62	8.48	39.82	3.12	2.23	4.13	0.45	1.67	1.56	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	40.56	8.43	38.33	3.97	1.61	4.59	0.25	2.60	1.12	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	51.75	9.79	37.06	3.26	1.05	4.78	0.23	1.63	1.17	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	47.15	10.86	45.53	0.69	1.39	5.08	0.23	2.08	3.70	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.33	5.89	35.19	2.33	1.23	2.88	0.00	2.74	1.23	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	41.45	7.87	38.73	2.87	1.06	3.93	0.15	1.21	0.76	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	48.56	7.88	33.33	2.33	0.90	2.87	0.54	2.15	1.61	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.10	7.17	32.42	2.87	1.15	4.16	0.29	1.29	0.86	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.12	8.37	41.53	2.90	0.97	3.65	0.54	1.61	1.50	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	48.24	5.09	32.31	1.55	1.55	3.98	0.22	1.99	1.55	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.16	6.69	29.06	2.10	1.34	4.21	0.19	1.15	0.96	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.18	7.73	32.98	2.42	1.40	2.89	0.19	1.68	1.86	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	34.76	4.51	38.71	2.07	2.82	4.51	0.19	2.25	1.32	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.78	4.64	33.71	1.99	0.80	4.51	0.27	1.73	0.53	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	46.43	10.61	44.78	3.60	1.27	3.80	0.29	2.24	2.24	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	43.73	8.59	38.96	1.91	0.95	4.77	0.00	1.53	1.34	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.53	4.91	36.95	1.50	0.85	2.99	0.11	1.50	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	35.60	8.41	35.88	2.52	1.96	4.48	0.28	1.12	1.12	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	44.26	6.67	34.86	1.20	1.20	4.10	0.34	1.54	1.03	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	17.69	3.65	27.17	2.37	0.91	2.73	0.00	1.09	1.09	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	46.36	7.48	44.27	3.31	0.74	3.68	0.12	1.47	2.08	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	47.01	10.75	42.85	2.69	1.88	4.16	0.27	1.48	1.75	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.81	4.25	35.15	3.07	1.18	4.25	0.47	2.36	1.42	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	47.62	6.35	41.67	3.17	2.98	4.56	0.00	2.58	2.98	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.91	7.02	28.53	3.27	1.17	3.74	0.23	2.34	1.40	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.02	5.60	31.31	3.53	1.24	3.94	0.21	2.07	0.41	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	38.05	5.53	38.71	2.43	1.11	3.54	0.66	1.99	1.99	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	38.43	6.06	34.47	2.09	1.04	3.76	0.21	1.67	2.51	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	25.44	6.59	33.65	2.15	1.21	4.44	0.00	2.15	1.75	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	46.32	10.05	43.77	2.55	1.36	5.11	0.68	2.04	1.70	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	48.78	8.68	37.02	2.51	1.35	4.24	0.00	1.54	1.16	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.29	5.50	39.89	2.24	1.55	4.64	0.00	1.55	2.24	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	49.52	7.54	33.47	1.65	1.37	5.21	0.00	2.06	2.06	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	43.18	5.75	38.74	2.13	1.15	3.28	0.33	1.48	1.48	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.37	5.79	35.45	2.90	1.36	4.09	0.34	2.05	0.51	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	62.73	14.20	51.93	2.96	1.92	4.88	0.89	1.48	1.63	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.05	5.86	42.65	3.20	1.07	4.80	0.53	3.73	2.93	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	43.83	10.78	63.05	3.18	2.49	8.85	0.41	3.46	1.38	3.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	81.19	14.29	75.48	5.24	2.14	6.19	0.00	4.05	2.38	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	64.49	12.90	66.91	2.82	2.02	7.86	0.20	2.62	4.64	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.02	7.44	55.56	3.20	0.94	5.74	0.38	2.26	1.22	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	79.31	19.21	85.94	4.89	2.79	9.78	0.70	2.79	3.14	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	65.88	12.09	65.88	3.32	1.51	7.56	0.60	1.51	3.32	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	25.82	7.59	55.56	2.45	1.84	5.75	0.61	1.35	2.69	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	36.68	7.42	51.38	1.75	1.89	5.82	0.00	2.04	2.62	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	57.80	14.60	55.98	3.04	0.61	6.69	0.00	3.04	3.65	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	23.21	6.33	48.83	0.60	0.90	4.82	0.00	1.81	2.11	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	70.80	14.02	93.19	3.39	1.81	16.06	0.68	2.94	3.17	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	50.32	11.68	82.67	1.80	3.29	12.58	0.00	2.40	3.29	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	38.49	9.45	77.81	3.07	2.60	11.69	0.47	4.37	3.07	4.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.39	11.31	81.32	5.34	1.71	10.25	0.43	4.48	2.35	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	35.46	4.81	39.66	3.61	2.40	9.62	0.60	2.40	2.40	2.40
Schwann Cells, donor1	11498-119F4	74.66	32.72	15.80	16.17	9.22	1.69	1.13	1.50	0.38	0.75
Schwann Cells, donor2	11578-120F3	23.82	6.80	3.40	10.21	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	51.26	15.34	7.01	7.45	5.92	1.31	0.88	0.44	0.44	0.22
Sebocyte, donor1	11220-116B5	28.48	13.15	1.64	4.38	4.93	1.10	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	8.73	3.68	1.38	1.84	1.38	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	9.69	3.50	1.65	1.03	1.44	0.21	0.00	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	39.76	4.97	9.94	4.97	0.00	0.00	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	8.47	0.00	2.82	0.00	5.65	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	95.72	25.69	20.76	13.11	9.50	1.23	1.23	0.88	0.35	1.23
Skeletal Muscle Cells, donor2	11358-117H8	74.45	26.75	17.35	5.06	9.40	0.00	0.72	0.00	2.17	2.89
Skeletal Muscle Cells, donor3	11430-118G8	51.00	13.38	6.69	6.69	7.52	3.34	0.00	2.51	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	28.75	9.43	3.77	3.61	4.08	0.00	0.31	0.47	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	32.85	9.66	5.35	2.38	2.53	0.74	0.15	0.74	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	30.93	10.00	3.54	3.23	2.31	1.08	0.92	0.46	0.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	99.92	25.08	17.39	9.45	9.45	3.28	0.88	1.01	0.63	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	97.46	27.68	16.12	8.70	6.42	2.85	1.14	1.28	0.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	78.08	25.89	11.01	6.65	4.66	1.29	0.60	0.69	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	69.00	19.88	24.60	16.93	10.62	1.52	2.44	0.84	0.76	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	94.81	28.23	17.37	7.96	2.90	1.45	0.00	2.17	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	112.28	36.05	20.50	17.20	8.67	1.93	1.38	2.06	1.10	0.41
Skin - palm, donor1	10286-104F7	16.12	2.69	8.06	0.00	0.00	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.10	2.74	1.30	2.59	1.73	0.00	0.43	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	3.27	0.00	0.00	1.64	1.64	0.82	0.82	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.96	4.02	0.00	1.56	1.30	0.00	0.39	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.17	4.17	2.09	1.95	1.67	0.42	0.00	0.14	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	10.83	4.36	0.98	2.11	0.56	0.28	0.28	0.14	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	13.74	13.74	1.06	4.23	2.33	0.21	0.21	0.00	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	17.91	10.49	1.20	2.47	1.50	0.07	0.22	0.15	0.45	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.63	1.85	0.93	0.93	0.93	0.00	0.93	0.00	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.90	8.67	10.23	2.67	13.12	1.33	0.44	1.11	0.89	2.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	6.47	1.18	2.94	2.35	0.00	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	92.60	36.02	30.94	15.47	17.46	4.20	1.10	1.10	1.55	2.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	7.88	3.54	1.97	3.94	0.00	0.39	1.58	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	6.18	2.32	1.55	3.86	0.00	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	98.07	42.03	114.09	11.01	6.00	4.00	1.00	1.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.81	5.59	3.33	4.39	4.39	0.40	0.27	0.27	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.63	4.21	2.66	2.66	0.66	0.22	0.22	0.44	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.17	2.05	0.38	1.54	0.90	0.00	0.26	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.51	7.16	5.54	1.95	4.56	0.65	0.33	0.33	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.78	11.52	10.04	3.25	5.32	0.30	0.30	0.59	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.35	8.11	9.54	1.99	3.42	0.71	0.43	0.57	0.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	81.83	24.56	10.57	7.48	10.25	0.98	1.46	1.63	0.33	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	73.37	23.44	14.92	7.31	7.61	1.22	0.61	0.00	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.28	4.80	9.34	3.54	3.79	1.77	0.00	0.51	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	18.36	12.24	0.00	12.24	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	5.25	1.43	3.81	2.86	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	63.12	15.78	19.17	5.01	7.08	0.15	0.44	0.88	0.15	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	61.99	20.45	27.77	4.95	6.46	0.65	0.86	0.65	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	68.85	27.92	17.95	6.30	4.30	1.47	0.52	0.73	0.42	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	21.66	6.65	4.80	3.56	3.56	1.24	0.62	0.77	0.62	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	3.23	0.00	0.00	3.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	27.79	10.46	3.59	6.28	6.57	0.30	0.30	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	143.39	55.99	59.40	18.09	9.22	1.37	2.73	2.05	0.68	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	88.50	26.23	49.08	7.46	11.39	1.33	1.10	1.02	0.86	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	3.32	0.40	1.11	0.20	0.60	0.20	0.00	0.20	0.20	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	124.47	57.57	33.91	16.38	20.71	10.24	1.37	3.19	2.05	4.32
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.70	1.81	6.04	3.62	4.83	1.21	0.00	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	73.12	37.88	9.54	11.92	6.09	1.32	1.06	0.79	0.26	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	19.44	9.85	6.13	3.46	2.80	0.93	0.67	0.93	0.53	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.60	22.16	14.40	4.76	5.89	1.00	0.50	0.63	0.88	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	46.93	10.40	9.64	3.04	8.62	1.01	0.51	0.51	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	31.21	8.29	3.92	4.07	3.77	0.60	0.30	0.60	1.21	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	32.26	9.75	14.25	2.25	7.50	3.00	0.00	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	5.17	1.29	2.58	1.29	2.58	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	22.32	5.58	4.19	2.79	3.26	0.47	0.00	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	49.48	13.63	10.10	7.57	9.09	2.02	1.51	0.00	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	30.71	16.92	10.97	10.97	12.54	2.51	1.25	0.94	0.63	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	43.07	19.17	7.08	5.60	9.73	0.88	0.29	1.18	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	69.23	28.24	5.50	10.91	4.50	0.83	0.83	0.25	0.42	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	118.19	32.70	14.48	9.34	14.48	0.93	2.34	0.93	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.85	3.89	3.60	1.15	3.17	0.14	0.29	0.14	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	32.12	12.24	2.80	3.82	3.06	0.51	1.02	0.76	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	26.51	6.58	3.57	3.20	1.13	0.19	0.56	0.19	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	147.43	60.23	29.91	15.65	10.90	1.96	0.98	2.10	0.56	1.96
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	131.30	67.20	34.69	14.41	11.65	1.84	1.42	1.51	0.92	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	120.00	28.57	40.95	4.76	14.76	3.81	0.48	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.59	6.12	2.20	1.71	3.18	0.49	0.00	0.49	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.55	13.04	7.73	3.54	6.19	0.88	0.44	1.77	0.88	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.67	9.36	5.85	3.22	4.39	0.88	0.00	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	128.86	21.19	27.21	11.86	6.22	3.50	1.75	0.78	0.19	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.46	0.53	2.91	0.26	1.32	0.79	0.00	0.53	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	26.78	4.09	4.46	2.23	2.60	0.37	0.00	0.37	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	37.73	3.23	3.95	2.52	8.98	1.44	0.36	1.44	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.22	1.14	1.70	0.00	1.14	0.28	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	30.72	2.76	4.73	4.73	2.36	1.18	0.39	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	49.01	3.56	12.95	3.05	6.60	3.56	0.51	1.27	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	76.27	6.79	11.98	5.19	7.19	2.40	0.80	0.40	0.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	51.83	7.11	10.03	1.25	6.27	2.09	0.00	0.42	0.42	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	67.84	7.33	13.29	5.50	6.88	4.13	0.46	1.38	1.38	1.38
Synoviocyte, donor1	11291-117A4	2.86	0.50	1.51	0.50	1.18	0.17	0.00	0.00	0.17	0.17
Synoviocyte, donor2	11368-117I9	31.35	10.23	13.75	2.18	3.35	4.02	0.17	1.84	1.51	0.84
Synoviocyte, donor3	11440-118H9	7.82	1.79	6.70	1.34	1.79	1.79	0.45	0.45	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	92.55	21.44	13.58	10.01	8.22	2.50	0.71	0.00	0.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	5.95	3.96	1.98	1.98	5.95	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	144.49	44.92	18.99	12.74	12.74	2.55	2.78	0.93	0.69	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	8.60	2.22	0.86	1.22	1.43	0.07	0.07	0.07	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	7.34	3.09	0.77	1.93	0.77	0.00	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	2.29	0.00	1.72	1.15	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	9.84	3.94	6.52	0.86	0.25	0.86	0.12	0.49	0.37	0.62
Urethra, donor2	10319-105A4	62.94	7.19	26.98	5.40	5.40	3.60	3.60	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	32.94	17.27	3.98	5.05	9.56	0.00	0.53	0.53	0.53	0.27
Urothelial Cells, donor2	11600-120H7	22.03	8.41	4.41	1.60	3.20	0.40	0.40	1.20	0.00	0.40
Urothelial Cells, donor3	11681-122H7	18.57	6.19	2.06	1.15	2.06	0.92	0.23	0.23	0.46	0.00
Urothelial cells, donor0	11216-116B1	36.55	9.81	4.01	1.11	2.45	0.45	0.00	0.45	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	0.00	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.00	0.00	0.00	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	109.79	52.55	16.16	16.90	16.04	0.62	2.34	1.11	0.99	0.74
Wilms' tumor cell line:HFWT	10597-108E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	91.06	36.03	18.99	12.57	9.78	15.92	1.96	1.68	1.12	1.40
achilles tendon, donor2	10292-104G4	6.20	2.07	14.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	45.38	10.71	2.80	1.78	2.55	0.76	0.00	0.76	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	118.64	36.68	13.93	16.95	2.79	2.09	1.86	1.63	0.23	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	44.99	16.62	3.44	5.34	1.07	0.83	0.24	0.83	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	4.08	0.27	0.27	0.27	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	7.87	1.41	3.09	1.41	0.28	1.12	0.00	1.12	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.19	0.85	1.48	0.00	0.00	0.00	0.00	0.42	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	65.21	18.95	5.73	4.85	6.61	1.32	1.32	0.88	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.53	0.41	2.45	0.00	0.00	0.41	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	6.21	0.39	4.66	0.00	0.00	0.39	0.00	0.78	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	7.80	27.30	11.70	19.50	3.90	0.00	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	40.43	5.81	9.30	3.25	2.79	1.63	0.00	2.09	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4.40	0.52	1.04	0.78	0.00	1.29	0.00	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.68	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.41	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.30	0.00	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.00	0.33	1.67	0.33	0.00	0.33	0.00	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	252.72	35.31	11.15	22.30	7.43	0.00	0.00	1.86	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.44	0.00	10.03	0.00	0.00	2.18	0.00	2.18	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	127.46	26.24	9.37	20.62	3.75	1.87	1.87	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	102.91	47.10	9.89	21.43	11.07	1.65	0.94	0.71	0.94	0.00
adipose tissue, adult, pool1	10010-101C1	7.14	1.86	8.84	0.31	0.47	1.24	0.00	0.31	0.00	0.16
adipose, donor1	10184-103D4	368.27	133.70	7.62	114.94	14.07	0.59	6.45	0.00	1.76	0.59
adipose, donor2	10185-103D5	241.28	191.81	29.20	139.50	11.35	6.08	18.25	0.41	0.41	2.03
adipose, donor3	10186-103D6	183.25	161.19	31.59	144.59	15.79	7.62	17.97	0.27	2.18	3.27
adipose, donor4	10187-103D7	135.21	65.01	9.53	55.47	12.13	5.20	4.33	0.00	0.00	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2.53	0.47	0.63	0.00	0.00	0.00	0.00	0.32	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	10.91	0.00	3.64	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	2.09	0.70	0.46	0.00	0.23	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	74.72	29.75	38.88	5.75	3.38	1.35	0.68	0.34	1.01	2.03
amniotic membrane cells, donor3	12237-129G5	0.88	0.00	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	1.19	1.19	2.37	1.19	1.19	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	8.72	2.84	4.06	2.23	0.00	0.41	0.20	0.20	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	6.13	0.65	2.26	1.61	1.61	0.00	0.00	0.32	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	89.13	24.57	12.10	3.69	5.73	1.27	0.38	1.15	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	103.55	31.07	40.08	8.02	11.69	2.34	0.33	6.01	1.00	1.34
aorta, adult, pool1	10052-101G7	9.02	4.31	6.08	1.57	1.18	0.39	0.00	0.20	0.20	0.39
appendix, adult	10189-103D9	12.42	3.88	24.84	2.72	0.78	1.94	0.00	0.39	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	206.02	34.74	27.17	15.82	40.58	3.78	1.72	3.44	1.38	2.06
artery, adult	10190-103E1	2.72	1.36	2.72	0.00	0.00	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	100.97	50.12	72.29	57.08	6.52	7.82	4.49	5.50	3.48	2.17
b cell line:RPMI1788	10427-106D4	0.00	0.30	0.00	0.00	0.00	0.15	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.71	2.22	4.16	0.83	0.55	0.28	0.00	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.71	3.87	5.06	1.49	4.17	0.40	0.99	0.60	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	36.32	22.76	15.57	5.69	1.17	1.67	1.17	0.17	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.36	1.68	2.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	10.32	2.06	16.62	0.98	1.20	1.52	0.00	0.11	0.00	0.65
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	0.00	0.86	0.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	23.62	3.37	20.24	2.02	2.02	6.07	0.00	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	3.08	2.05	3.08	2.05	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	4.12	2.23	4.68	1.22	0.56	1.00	0.22	0.11	0.11	0.00
brain, fetal, pool1	10085-102B4	24.04	16.03	2.67	8.01	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	3.63	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.50	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	8.21	3.16	6.31	0.00	0.00	2.53	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	87.66	179.12	18.04	69.62	12.96	4.07	6.86	0.76	1.65	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	88.44	20.10	19.79	15.15	25.67	0.62	1.24	0.00	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	139.97	6.68	4.83	3.68	18.88	0.46	1.15	0.46	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.30	6.54	3.39	2.66	2.66	1.21	0.24	0.24	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	33.85	10.81	1.41	2.82	0.00	0.00	0.00	0.94	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	317.09	208.70	96.04	164.07	114.08	14.55	25.60	6.23	7.33	5.03
carcinoid cell line:SK-PN-DW	10719-109I8	5.39	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	181.00	60.95	13.58	22.89	8.52	2.93	3.19	0.53	0.27	0.27
caudate nucleus - adult, donor10196	10177-103C6	1.15	1.15	3.45	0.00	1.15	1.15	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	5.69	1.84	5.52	0.84	1.00	0.67	0.17	0.17	1.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	2.29	3.82	2.29	0.76	1.53	2.29	0.76	0.00	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	1.83	2.56	2.56	3.66	0.73	0.00	0.00	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	0.00	5.83	2.91	0.00	0.00	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	5.34	4.91	3.20	1.49	2.56	1.07	0.00	0.00	0.21	0.00
cerebellum, adult, pool1	10083-102B2	4.14	6.90	1.38	2.41	1.03	0.00	0.34	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	8.30	1.66	2.49	9.13	3.32	0.00	0.00	0.00	0.00	1.66
cerebral meninges, adult	10188-103D8	10.59	3.78	6.30	1.26	1.26	1.26	0.00	0.50	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	1.46	1.46	2.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	22.21	11.27	6.79	4.31	0.83	0.66	0.99	2.32	1.82	0.33
cervix, adult, pool1	10013-101C4	75.49	25.30	116.01	7.14	6.40	2.94	1.26	1.57	1.26	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2.93	0.70	1.39	0.14	0.14	0.14	0.00	0.14	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.25	0.00	0.12	0.12	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	42.26	70.48	4.68	14.54	3.20	2.34	2.59	1.60	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	29.41	30.60	1.19	14.23	1.66	0.24	1.19	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	5.98	3.70	3.70	0.85	0.85	0.57	0.00	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	45.94	19.09	8.55	3.08	3.28	0.30	0.30	0.89	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	4.40	2.20	2.75	0.00	0.55	0.00	0.00	0.00	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.13	7.30	4.23	3.07	4.03	0.38	0.00	0.58	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.18	1.27	0.84	0.63	0.63	0.21	0.00	0.84	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	107.09	24.65	16.44	17.46	6.42	0.77	1.03	0.51	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	111.75	31.44	13.79	22.01	6.77	0.48	1.94	0.24	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	102.62	32.17	14.86	18.32	7.74	1.02	0.81	1.02	0.20	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	33.27	2.06	1.47	2.94	2.65	0.29	0.59	0.88	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	2.61	0.52	0.26	0.52	0.26	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	14.40	1.37	0.46	0.23	0.91	0.00	0.00	0.23	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	23.77	10.41	10.76	4.51	0.87	2.95	0.35	0.52	0.87	0.52
colon carcinoma cell line:CACO-2	10513-107D9	131.61	81.09	5.49	32.95	13.73	0.92	4.58	1.10	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	12.54	1.14	0.00	1.52	3.04	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	4.76	3.57	3.57	2.38	0.00	1.19	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	54.17	30.32	17.39	10.11	5.05	3.88	1.29	1.18	2.59	0.94
colon, fetal, donor1	10070-101I7	23.48	11.12	12.98	4.33	2.47	1.24	1.24	1.24	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	77.92	18.33	0.00	4.58	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.90	0.85	4.67	1.27	1.70	5.95	0.00	0.42	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	18.26	4.08	14.34	2.11	2.57	3.77	0.30	0.60	0.15	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	22.14	5.22	15.79	2.82	4.09	5.78	0.56	0.71	0.14	1.13
corpus callosum, adult, pool1	10042-101F6	6.19	4.09	7.19	1.77	0.55	0.88	0.22	0.55	0.33	0.66
cruciate ligament, donor2	10295-104G7	6.48	0.00	4.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	16.05	4.82	8.03	0.00	1.61	0.80	0.00	0.80	0.80	0.00
diencephalon, adult	10193-103E4	2.16	1.92	2.88	0.48	0.48	0.72	0.00	0.48	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	153.86	75.39	98.73	111.29	35.65	12.05	13.33	6.41	5.90	3.85
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	23.92	3.49	12.46	1.50	2.99	1.00	0.50	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	57.61	38.89	33.13	8.64	4.32	1.44	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	63.27	16.92	56.64	16.18	7.36	4.41	0.74	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	32.21	11.81	20.89	2.56	5.45	1.49	0.17	0.74	0.91	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	39.08	23.10	6.66	27.54	7.99	1.55	4.22	0.89	1.11	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	63.77	21.64	12.04	16.19	5.59	1.72	1.72	0.72	1.29	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.10	7.04	0.00	3.35	14.41	0.00	0.67	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	395.46	79.20	21.02	23.56	41.50	2.54	4.17	1.09	0.72	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	95.84	34.57	43.42	20.42	17.85	19.46	1.93	3.54	6.75	4.34
epidermoid carcinoma cell line:A431	10426-106D3	22.45	7.00	12.89	4.45	2.45	7.45	0.67	1.89	1.56	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	66.32	25.74	23.98	16.28	5.94	6.93	0.99	1.32	0.99	1.10
epididymis, adult	10197-103E8	47.93	11.30	41.23	2.30	2.93	2.30	0.21	0.84	0.63	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	81.25	11.35	11.35	4.79	3.73	1.06	0.89	0.71	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.00	0.00	0.13	0.00	0.00	0.26	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.00	0.00	0.10	0.00	0.00	0.10	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.00	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	5.20	2.12	6.90	0.64	0.85	0.85	0.00	0.32	0.53	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	425.43	149.16	102.32	62.49	112.84	5.01	7.89	0.88	1.38	2.25
eye - muscle inferior rectus, donor1	10272-104E2	21.73	0.00	4.83	2.41	0.00	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	0.00	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	8.93	2.98	8.93	0.00	0.00	0.00	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	0.00	8.03	1.15	1.15	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	30.61	4.37	2.91	0.00	1.46	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	48.05	35.34	20.08	5.08	8.14	1.02	0.76	0.76	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	4.10	0.90	0.90	0.00	0.26	0.00	0.13	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	46.30	10.21	5.70	2.85	0.95	0.24	0.24	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	4.79	3.10	4.41	1.41	0.56	1.13	0.09	0.28	0.09	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	115.60	58.55	31.83	22.82	8.71	5.40	2.70	0.90	3.90	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	709.82	201.43	86.50	44.35	53.76	26.15	3.93	3.66	2.01	3.75
gall bladder, adult	10198-103E9	34.77	13.28	43.94	4.83	5.79	1.21	0.72	1.69	0.48	1.45
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	74.56	39.08	35.91	7.82	4.01	7.82	0.42	4.86	3.38	3.38
gastric adenocarcinoma cell line:MKN45	10612-108F9	60.73	28.82	5.03	24.37	26.50	1.74	2.32	0.39	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	121.49	20.33	8.69	14.10	18.36	0.66	1.64	1.48	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	89.69	5.49	8.24	1.83	5.49	0.92	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	68.08	27.87	17.82	14.16	5.25	5.48	1.37	1.14	0.91	0.91
giant cell carcinoma cell line:LU65	10487-107B1	6.31	1.49	5.16	0.57	1.38	0.46	0.11	0.23	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	77.12	12.32	16.80	2.94	13.72	4.06	0.28	2.52	0.84	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	131.44	44.15	40.41	21.45	6.98	1.50	1.25	3.74	3.99	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	0.00	0.00	0.21	0.00	0.00	0.53	0.00	0.00	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	0.00	0.00	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	185.54	51.32	13.24	14.13	10.04	2.76	1.43	0.66	0.44	0.55
glioma cell line:GI-1	10413-106B8	311.91	98.41	71.46	21.09	18.74	2.64	1.76	3.51	0.59	2.34
globus pallidus - adult, donor10196	10175-103C4	2.19	0.73	0.73	0.73	0.00	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	3.91	1.95	3.42	0.49	0.00	0.00	0.00	0.00	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	6.85	0.00	1.37	1.37	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	2.13	0.00	2.66	1.60	1.07	0.00	0.00	0.53	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	12.24	2.45	4.89	2.45	0.00	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	10.45	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	4.80	0.00	0.96	0.00	0.32	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	107.43	47.29	33.97	72.54	27.09	9.64	5.97	1.38	0.46	4.13
hIPS +CCl2, biol_rep2	14384-156C1	84.59	24.23	31.09	89.17	21.03	8.69	7.32	0.91	0.46	5.03
hIPS +CCl2, biol_rep3	14385-156C2	77.29	23.19	36.71	103.05	35.43	11.59	14.81	1.29	1.29	5.15
hIPS, biol_rep1	14380-156B6	21.56	8.62	12.94	97.74	10.06	12.94	4.31	1.44	0.00	8.62
hIPS, biol_rep2	14381-156B7	61.73	17.83	24.01	86.42	22.63	17.15	8.23	1.37	1.37	3.43
hIPS, biol_rep3	14382-156B8	11.03	5.52	6.62	5.52	3.31	6.62	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	14.95	4.19	25.41	1.20	1.20	1.20	0.60	0.00	0.60	1.49
heart - pulmonic valve, adult	10206-103F8	6.01	1.31	6.80	0.52	0.52	2.35	0.00	0.78	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	2.50	0.00	11.66	0.00	0.00	0.83	0.00	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	42.44	24.28	9.39	17.75	1.84	1.02	2.04	1.22	2.04	0.41
heart, adult, diseased, donor1	10051-101G6	3.41	0.43	2.55	0.00	0.00	0.43	0.43	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	1.38	0.46	3.22	0.46	0.00	0.23	0.00	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	80.19	39.94	213.99	9.86	7.70	2.16	1.75	3.08	2.26	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	34.25	9.56	9.87	1.54	2.16	1.23	0.62	0.31	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	266.38	92.76	5.95	49.95	27.35	8.32	10.70	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	152.82	57.68	17.35	23.31	9.83	8.95	3.43	1.22	0.99	2.98
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	157.79	67.36	16.14	22.94	10.20	11.53	4.85	0.73	1.34	3.16
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	148.14	62.25	17.68	23.44	9.60	11.62	3.44	1.52	0.91	3.54
hepatoma cell line:Li-7	10484-107A7	122.78	33.81	45.71	10.34	3.78	8.01	1.78	0.78	0.78	2.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	3.79	0.95	1.89	0.95	0.00	0.95	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	6.94	4.29	4.08	0.82	0.61	0.61	0.00	0.41	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	2.49	0.00	2.99	1.49	0.00	0.00	0.00	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	2.47	1.06	1.76	2.82	1.06	0.00	0.35	0.35	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	173.34	30.52	18.31	51.27	22.58	1.22	6.10	0.00	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	144.52	50.86	15.32	47.32	18.85	3.34	5.89	0.59	0.79	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	149.29	33.01	14.73	59.41	23.87	2.03	6.09	1.27	1.02	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	217.09	71.05	15.22	147.17	11.84	1.69	11.28	0.00	1.13	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	276.29	120.33	16.53	162.42	12.14	3.87	15.49	0.52	1.03	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	263.45	79.34	16.32	187.15	15.18	3.04	16.70	0.38	0.38	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	181.01	81.46	37.08	223.05	11.97	13.14	26.86	2.04	0.58	5.55
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	246.88	185.70	56.01	239.77	14.22	8.83	38.56	2.59	1.51	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	156.82	66.31	72.99	179.34	21.27	12.51	20.44	2.92	0.83	7.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	236.56	226.61	82.88	386.68	31.97	10.42	46.17	3.55	1.42	6.87
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	200.41	223.08	85.18	293.79	18.64	9.64	43.88	3.05	1.77	7.88
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	222.86	238.35	109.75	387.15	29.63	10.77	38.38	4.04	1.35	6.06
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	124.09	45.69	12.05	47.88	18.78	4.38	6.10	0.31	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	128.72	46.67	11.30	52.08	24.07	3.44	5.90	0.49	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	103.86	13.96	8.73	34.91	25.31	6.11	5.24	1.75	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	281.78	113.78	11.07	152.16	11.26	3.82	16.80	0.00	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	255.54	113.82	9.59	139.98	13.08	3.05	11.77	0.44	0.87	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	212.90	53.97	7.00	101.45	9.00	2.50	5.50	0.50	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	383.38	206.85	33.72	200.64	13.56	2.83	24.30	0.94	1.51	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	374.69	220.54	38.20	267.37	19.55	3.18	21.83	1.82	1.36	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	268.76	118.72	31.95	205.48	13.16	5.01	20.99	0.00	0.31	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	291.17	221.76	46.54	220.13	32.33	7.02	23.84	0.98	1.96	2.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	293.21	221.22	47.32	249.38	33.68	7.84	27.58	0.29	2.03	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	245.12	139.00	43.94	197.29	29.89	6.28	29.29	1.79	0.90	3.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	156.85	49.14	23.28	49.70	19.40	4.43	8.50	0.18	0.18	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	156.62	64.19	17.12	57.06	23.39	5.71	6.56	1.14	0.57	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	186.19	40.42	21.23	57.98	32.66	4.08	9.39	1.22	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	298.21	131.33	29.57	152.45	21.83	7.04	16.20	1.41	2.11	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	250.86	108.64	25.66	127.65	14.57	6.65	12.35	0.95	0.63	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	295.66	90.79	23.00	134.06	18.46	7.57	13.92	1.21	2.12	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	320.10	188.75	61.54	210.47	23.79	9.31	20.68	4.14	1.55	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	255.04	171.35	54.46	195.26	20.59	5.31	26.57	0.66	1.99	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	276.80	116.47	77.73	180.60	30.78	12.83	23.60	2.05	2.31	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	243.89	175.63	87.18	206.05	32.98	10.23	23.01	1.53	2.30	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	210.51	124.94	69.66	237.77	25.75	15.14	24.23	0.00	3.79	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	180.46	90.74	57.47	146.18	27.56	9.07	17.47	1.01	2.02	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	150.46	60.38	23.91	69.31	26.57	9.18	6.28	0.97	0.00	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	126.12	26.74	21.39	53.48	26.29	9.36	4.01	0.45	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	140.00	45.85	20.00	51.22	22.44	7.80	5.85	0.98	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	272.92	116.13	25.67	178.79	12.22	5.81	18.34	0.92	0.31	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	611.61	71.57	19.52	198.45	16.27	0.00	6.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	311.09	72.15	20.85	176.06	16.55	7.94	18.86	1.65	0.66	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	251.76	151.05	68.96	303.75	16.42	13.14	37.76	1.64	2.74	5.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	243.19	125.57	78.89	268.88	18.09	11.94	26.78	2.90	3.62	7.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	225.98	95.02	56.23	245.91	11.74	13.52	26.69	0.71	1.78	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	97.86	60.86	36.99	151.56	9.55	7.16	19.09	0.00	2.39	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	188.92	171.58	55.25	286.02	25.73	9.21	36.56	2.30	1.35	3.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	113.95	69.23	28.29	149.51	19.13	6.73	23.71	0.54	0.54	2.96
immature langerhans cells, donor1	11904-125F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	3.12	1.32	4.92	1.04	0.47	0.38	0.00	0.38	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	5.81	1.40	6.31	0.40	0.60	0.50	0.10	0.40	0.20	0.00
kidney, fetal, pool1	10045-101F9	101.01	47.82	42.30	14.22	6.86	0.99	1.98	2.33	1.70	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	119.72	34.51	15.34	9.09	18.46	1.70	1.56	2.13	0.71	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.85	2.07	0.69	0.28	1.11	0.00	0.00	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	47.71	23.49	8.62	4.77	1.47	0.37	0.55	0.18	0.18	0.00
left atrium, adult, donor1	10079-102A7	5.99	2.72	5.99	0.00	1.09	1.09	0.00	1.09	0.54	0.54
left ventricle, adult, donor1	10078-102A6	2.53	0.51	2.02	0.00	0.51	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	95.56	45.62	30.18	11.86	22.63	1.44	1.80	4.31	2.16	3.23
leiomyoma cell line:15242A	10570-108B3	43.48	10.33	7.07	3.80	16.85	1.09	1.09	2.17	0.54	0.00
leiomyoma cell line:15425	10571-108B4	71.15	33.02	21.37	8.50	15.05	2.67	0.97	1.46	1.46	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	69.01	12.55	17.77	3.14	4.18	6.27	2.09	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.44	2.60	1.18	1.30	4.60	0.24	0.12	0.12	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	11.25	2.81	1.25	0.31	1.72	0.00	0.31	0.00	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	346.88	177.76	60.80	34.11	9.87	14.38	5.00	3.66	2.07	3.17
liver, adult, pool1	10018-101C9	1.13	0.32	2.11	0.00	0.16	0.00	0.00	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	18.81	8.47	6.58	1.88	0.94	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	2.92	0.58	1.75	0.29	0.15	0.00	0.15	0.15	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	5.72	1.85	4.43	0.74	1.29	0.18	0.00	0.18	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	6.21	1.69	2.54	1.97	1.13	0.56	0.28	0.00	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	6.73	1.68	4.21	2.52	1.26	0.84	0.84	0.00	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	1.38	0.00	0.14	0.00	0.00	0.00	0.00	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	160.63	57.91	55.84	24.82	16.55	15.17	4.83	1.38	3.45	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	230.28	73.69	42.31	43.24	35.99	6.72	5.93	2.11	0.92	0.53
lung, adult, pool1	10019-101D1	12.99	2.95	9.21	0.59	0.59	1.06	0.24	0.24	0.24	0.24
lung, fetal, donor1	10068-101I5	31.11	10.56	44.24	10.27	5.42	1.43	0.00	2.85	0.29	1.14
lung, right lower lobe, adult, donor1	10075-102A3	11.46	3.21	10.08	0.92	0.46	1.37	0.46	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	3.79	0.95	1.89	0.95	0.47	0.00	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	4.16	0.00	1.97	0.22	1.10	0.22	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	25.48	13.59	14.44	8.49	8.49	5.95	0.00	2.55	2.55	0.00
mature adipocyte, donor1	12231-129F8	2.22	0.00	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	2.91	0.62	2.49	0.42	0.21	0.62	0.00	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	2.13	0.24	0.95	0.00	0.00	0.00	0.00	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	1.58	0.53	1.84	0.26	0.00	0.26	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	91.01	36.45	43.36	46.22	13.58	6.67	5.48	3.10	3.81	2.38
medial frontal gyrus - adult, donor10196	10170-103B8	1.13	1.13	1.13	1.13	0.00	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	3.68	0.74	3.31	0.92	0.37	0.37	0.00	0.00	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	1.27	0.64	1.27	0.32	0.32	0.32	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	4.26	0.43	0.85	1.28	0.43	0.00	0.43	0.00	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	1.52	0.34	3.04	0.84	0.34	0.34	0.17	0.17	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	2.76	1.49	4.03	1.06	0.00	0.64	0.21	0.00	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	0.00	3.85	1.93	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2.87	0.72	1.79	1.44	2.87	0.72	0.36	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	1.30	0.65	3.24	0.00	1.30	0.00	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	6.35	3.10	5.11	0.31	0.77	0.93	0.00	0.31	0.77	0.31
medulla oblongata, adult, pool1	10038-101F2	7.43	4.65	7.02	1.88	1.22	0.82	0.24	0.73	0.65	0.08
medulla oblongata, newborn, donor10223	10361-105F1	9.72	1.04	5.21	2.08	1.74	0.69	0.35	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	18.16	2.21	2.44	0.89	1.55	0.00	0.00	0.44	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	154.43	67.74	17.12	32.40	9.54	3.55	3.79	0.98	0.73	0.98
melanoma cell line:COLO 679	10514-107E1	7.47	1.29	1.87	0.43	0.43	0.29	0.00	0.14	0.14	0.00
melanoma cell line:G-361	10465-106H6	38.82	7.33	3.26	2.99	0.81	0.00	0.81	0.27	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	34.37	9.41	6.33	1.81	1.99	7.78	0.00	0.72	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	104.86	22.91	11.46	12.34	1.76	1.76	2.64	0.88	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	185.60	86.32	20.48	56.25	9.85	3.89	5.96	3.37	9.07	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	5.37	0.77	0.61	0.15	0.15	0.15	0.15	0.15	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	29.27	3.82	5.27	2.00	1.09	0.18	0.73	0.55	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.48	0.00	2.48	0.41	0.00	0.41	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.17	3.37	3.79	0.70	1.26	0.42	0.14	0.28	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.66	4.24	10.21	1.35	3.47	2.12	0.19	0.39	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	2.78	8.33	2.78	2.08	3.47	0.00	0.69	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.70	2.75	2.06	0.17	1.20	0.51	0.17	0.00	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.25	3.80	7.25	0.58	1.27	0.58	0.00	0.12	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.39	6.37	3.98	2.52	1.72	0.27	0.27	0.00	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	33.63	8.64	4.86	3.11	3.92	0.41	0.14	0.27	0.27	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.61	4.84	2.42	1.14	2.70	0.00	0.28	0.43	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	3.29	6.92	2.31	2.96	0.66	0.33	0.33	0.00	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	35.70	7.06	2.63	1.38	3.60	0.42	0.28	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.77	1.75	3.49	1.40	1.75	1.05	0.00	1.05	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.37	3.88	4.08	0.82	2.65	0.61	0.41	0.41	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.82	2.16	4.31	0.36	1.80	0.72	0.36	0.36	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	64.76	13.14	16.97	2.28	10.24	1.66	0.31	0.83	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.64	4.10	3.88	1.60	8.44	0.23	0.23	0.23	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.24	4.62	5.45	1.26	5.45	0.42	0.42	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.23	4.93	2.39	1.20	1.49	0.60	0.30	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.91	4.73	5.25	1.49	4.11	0.44	0.18	0.35	0.35	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	24.67	3.31	8.10	1.47	4.79	1.10	0.00	1.84	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.18	3.43	5.15	1.43	5.44	0.00	0.00	0.57	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	43.79	14.74	6.74	4.63	2.95	1.26	0.00	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	4.57	2.28	3.65	0.00	0.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.84	4.09	4.86	1.53	1.28	0.26	0.00	0.26	1.02	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.03	3.93	6.02	2.88	1.31	0.26	0.00	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.57	3.39	6.47	0.92	0.62	0.31	0.00	0.92	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	18.59	3.06	4.00	2.12	1.18	1.18	0.47	0.00	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	2.37	2.37	2.37	1.02	0.00	0.00	1.02	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	5.11	4.32	2.75	1.96	1.96	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.39	0.46	3.71	0.00	1.39	0.93	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	21.92	4.04	4.90	2.02	1.73	1.15	0.58	0.58	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.19	4.46	4.24	2.45	1.12	0.22	0.45	0.00	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.47	2.88	6.25	1.44	2.40	0.48	0.72	0.48	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	8.80	2.93	3.67	4.40	0.73	0.00	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.44	2.69	1.34	0.67	1.68	1.01	0.34	0.67	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.47	3.28	6.55	0.41	1.64	0.82	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.18	3.44	4.30	3.01	1.72	0.00	0.43	0.00	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	10.94	5.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	10.33	0.00	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	2.60	2.60	1.30	0.32	0.65	0.00	0.00	0.00	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	1.45	7.27	4.36	0.00	0.00	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.26	5.86	6.93	0.53	1.07	0.53	0.00	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	6.54	4.91	1.64	0.82	1.64	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.71	1.17	3.11	3.11	2.33	0.00	0.00	1.17	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	0.00	6.30	0.00	0.00	2.10	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	0.00	3.97	0.00	3.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	24.31	5.93	2.96	2.96	0.59	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	1.22	2.44	2.44	6.09	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	18.37	1.90	10.13	1.27	0.00	0.63	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.56	1.38	3.10	2.07	1.72	1.03	0.00	0.00	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	2.15	4.30	0.00	0.00	2.15	2.15	2.15	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	0.00	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	6.89	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	37.49	4.48	7.33	2.04	3.26	1.22	0.00	0.81	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	24.63	11.92	9.53	2.38	4.77	2.38	0.79	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	33.01	5.90	7.66	5.90	0.59	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.74	5.30	9.35	2.81	1.25	0.31	0.62	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	6.68	5.35	4.01	8.02	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	2.37	5.91	1.18	1.18	0.00	0.00	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	0.00	5.14	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	27.54	8.26	7.57	0.69	1.38	0.00	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	2.47	0.99	1.98	0.00	0.00	0.00	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	0.00	4.49	0.00	1.12	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.09	1.27	2.54	0.64	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.24	0.81	0.40	0.40	0.00	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	0.00	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	0.00	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.25	0.00	0.00	0.61	0.00	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.82	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.53	1.79	3.37	1.19	0.40	0.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.44	1.30	1.95	0.97	0.00	0.32	0.00	0.32	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	2.04	5.09	2.04	1.02	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.10	17.80	19.34	4.64	3.87	1.55	0.00	0.00	0.77	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	0.00	0.00	0.47	0.00	0.00	0.47	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	159.85	65.33	43.32	14.13	27.80	5.79	0.70	4.40	0.93	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	0.00	0.00	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1.54	0.10	0.82	0.00	0.10	0.21	0.00	0.00	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	75.12	52.20	22.70	14.07	6.81	2.27	0.45	1.59	0.68	1.36
mesothelioma cell line:Mero-41	10851-111F5	0.24	0.00	0.00	0.00	0.00	0.98	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.76	0.89	1.99	1.11	0.22	0.00	0.00	0.00	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	12.61	4.47	9.72	0.79	0.00	3.15	0.26	0.53	0.00	1.05
mesothelioma cell line:Mero-83	10854-111F8	19.06	2.89	5.96	2.21	1.19	1.02	0.34	0.68	0.68	0.68
mesothelioma cell line:Mero-84	10855-111F9	44.74	8.34	10.62	3.03	7.33	0.76	0.51	0.76	1.01	0.51
mesothelioma cell line:Mero-95	10856-111G1	128.16	37.27	21.95	22.15	19.46	2.07	1.66	1.66	3.11	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	53.34	12.09	8.94	4.47	12.42	1.16	0.66	1.99	1.49	0.50
mesothelioma cell line:NCI-H226	10846-111E9	34.03	13.39	5.43	4.89	6.52	1.45	0.90	0.18	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	111.38	61.15	17.94	26.48	15.72	7.86	4.61	1.37	1.02	1.37
mesothelioma cell line:NCI-H28	10845-111E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	61.78	19.24	23.84	7.86	12.19	9.21	0.54	1.35	0.54	3.79
migratory langerhans cells, donor1	11901-125F2	2.88	0.77	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.03	0.85	0.37	0.00	0.12	0.12	0.00	0.12	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	13.64	3.41	1.62	0.54	0.00	0.72	0.18	0.18	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	0.00	0.33	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.53	4.45	0.00	1.91	1.27	0.00	0.42	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.95	14.05	6.45	8.06	3.92	1.15	0.92	0.69	0.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.04	2.09	4.19	0.76	0.76	1.90	0.00	0.38	0.19	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	96.89	14.71	7.10	1.01	2.54	0.51	1.01	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1.77	0.39	1.37	0.00	0.39	1.18	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.48	8.13	0.67	2.12	0.56	0.22	0.11	0.22	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	13.68	6.03	1.40	1.54	0.37	0.07	0.00	0.22	0.07	0.07
nasal epithelial cells, donor2	12227-129F4	19.87	7.73	2.21	3.31	1.66	0.55	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	270.55	103.07	42.10	49.23	6.90	0.23	5.52	2.07	1.38	1.61
neuroblastoma cell line:NB-1	10539-107G8	455.93	84.75	323.84	41.53	35.36	1.68	4.30	8.42	10.29	7.48
neuroblastoma cell line:NBsusSR	10607-108F4	218.48	135.39	48.08	83.09	21.09	0.63	6.12	0.84	1.48	0.63
neuroblastoma cell line:NH-12	10555-107I6	191.20	70.81	96.53	29.44	8.76	0.37	2.98	1.30	1.86	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	323.81	71.88	47.68	13.28	7.59	0.00	0.24	1.19	1.19	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	49.10	12.83	10.14	4.28	3.80	0.00	0.48	1.43	0.79	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	11.27	2.21	2.82	0.60	0.40	0.00	0.00	0.20	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	118.25	9.54	12.08	1.27	3.18	0.64	0.64	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.64	5.06	3.19	1.86	0.80	0.53	0.00	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	209.20	49.38	10.99	13.36	2.54	1.35	1.01	3.38	0.51	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	44.03	4.80	0.00	0.80	0.80	0.00	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	182.75	96.50	27.25	21.48	20.84	5.13	0.96	1.92	2.56	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	98.80	33.90	24.17	9.72	4.99	4.73	1.05	0.79	1.58	1.31
nucleus accumbens, adult, pool1	10037-101F1	4.31	2.44	5.81	0.75	0.37	0.56	0.19	0.28	0.28	0.56
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	3.22	0.54	4.29	0.81	0.54	0.54	0.00	0.00	0.81	0.00
occipital cortex, newborn, donor10223	10355-105E4	1.82	0.36	3.28	0.36	1.46	0.00	0.00	0.00	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	2.62	0.79	4.46	1.05	0.00	0.00	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	53.64	21.03	12.87	9.44	2.15	0.43	1.72	0.43	0.43	0.43
occipital pole, adult, pool1	10036-101E9	5.28	2.92	4.18	1.81	0.47	0.71	0.24	0.08	0.00	0.32
olfactory region, adult	10195-103E6	5.16	1.15	4.01	0.38	0.57	0.76	0.38	0.38	0.38	0.19
optic nerve, donor1	10277-104E7	20.01	4.00	12.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	47.16	18.34	12.19	11.50	9.45	11.96	1.59	0.80	0.57	4.10
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	66.22	29.95	15.52	21.71	3.30	7.56	2.34	2.61	0.82	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.99	16.93	13.04	5.59	2.37	6.43	0.34	0.85	1.69	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	75.89	40.20	25.64	29.34	9.70	6.24	4.74	1.73	1.62	1.62
osteoclastoma cell line:Hs 706.T	10704-109H2	24.40	6.47	7.64	2.35	1.47	0.29	0.00	0.00	1.47	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.03	6.54	10.28	1.87	2.80	0.00	0.00	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	146.53	31.38	46.44	5.51	13.15	5.30	1.27	1.27	2.12	4.24
ovary, adult, pool1	10020-101D2	88.23	34.68	190.95	10.39	8.65	6.90	1.75	4.28	2.18	2.53
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	22.37	6.23	4.40	1.10	0.55	0.37	0.37	1.10	0.37	0.18
pancreas, adult, donor1	10049-101G4	16.93	2.82	11.29	0.94	0.94	0.94	0.94	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	73.08	26.40	15.33	6.13	4.60	2.73	1.02	2.21	0.85	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	163.76	74.68	38.58	16.89	17.72	3.97	1.32	2.32	1.32	0.99
paracentral gyrus, adult, pool1	10035-101E8	4.12	1.74	3.20	0.82	0.37	0.09	0.27	0.18	0.18	0.18
parietal cortex, adult, donor10258	10373-105G4	6.61	1.47	2.20	0.73	0.73	2.20	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	3.14	1.14	2.28	1.43	0.29	0.29	0.00	0.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	2.82	1.50	3.79	1.23	0.44	0.18	0.09	0.00	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	42.67	28.13	8.73	12.61	4.85	0.97	0.97	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	2.24	0.75	1.12	1.12	4.11	1.12	0.00	0.00	0.00	0.00
parotid gland, adult	10199-103F1	11.72	6.17	14.18	1.85	4.93	0.00	0.62	0.00	0.00	0.00
penis, adult	10200-103F2	16.11	4.30	13.43	0.00	4.30	1.07	0.00	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	27.33	6.14	3.72	1.67	3.53	0.19	0.00	0.56	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	102.86	48.81	42.69	20.54	15.44	10.64	2.77	4.08	3.35	1.17
pineal gland - adult, donor10196	10179-103C8	10.97	3.23	1.94	1.29	2.58	1.29	0.00	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	4.74	5.33	4.15	0.59	1.18	1.78	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	10.03	4.39	3.14	3.14	1.25	0.63	0.00	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	110.29	24.28	27.32	12.14	22.26	7.08	0.00	6.07	1.01	3.04
pituitary gland, adult, donor10252	10162-103A9	139.15	66.71	42.22	14.07	33.88	6.78	0.52	2.61	1.56	4.69
pituitary gland, adult, donor10258	10378-105G9	75.76	23.83	22.13	5.11	19.58	6.81	0.85	3.40	2.55	1.70
placenta, adult, pool1	10021-101D3	11.50	4.19	12.79	1.61	0.54	0.54	0.00	0.32	0.54	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	15.23	2.65	2.78	1.32	0.93	1.72	0.00	0.53	0.13	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.81	8.40	5.76	1.71	2.96	0.78	0.31	0.47	0.00	0.00
pons, adult, pool1	10033-101E6	2.24	1.03	1.98	0.77	0.09	0.43	0.00	0.17	0.26	0.17
postcentral gyrus, adult, pool1	10032-101E5	4.88	2.09	3.92	1.22	0.52	0.78	0.09	0.35	0.35	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	23.60	3.35	1.60	1.02	1.46	0.29	0.00	0.29	0.29	0.15
prostate cancer cell line:PC-3	10439-106E7	127.78	29.95	5.81	9.08	11.43	0.54	1.45	1.27	0.36	0.36
prostate, adult, pool1	10022-101D4	61.67	17.23	53.42	5.17	5.99	3.72	0.54	0.91	1.81	2.00
putamen, adult, donor10196	10176-103C5	3.30	1.65	3.54	0.47	0.47	0.47	0.00	0.00	0.47	0.24
putamen, adult, donor10252	10152-102I8	1.96	0.00	1.96	1.96	1.96	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	13.11	8.74	31.69	8.74	7.65	2.19	2.19	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	1.69	0.72	2.17	0.48	0.00	0.72	0.00	0.00	0.00	0.24
putamen, newborn, donor10223	10365-105F5	0.00	0.00	1.50	0.75	0.75	0.00	0.75	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	10.47	9.02	4.36	2.62	0.87	0.00	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	183.61	68.16	75.11	16.69	4.17	1.39	2.78	0.00	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.69	2.76	1.91	0.42	0.42	0.85	0.00	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	157.40	30.24	19.88	6.21	16.15	3.31	0.41	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	76.54	41.75	69.78	7.16	31.81	3.58	1.29	0.99	1.89	0.89
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.08	3.57	4.06	0.61	1.72	0.00	0.00	0.00	0.00	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	583.49	256.17	48.65	91.67	11.53	4.22	9.84	1.12	0.84	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	148.54	21.22	35.62	6.82	6.82	1.52	0.00	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	3.40	0.32	0.49	0.16	0.16	0.00	0.00	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	2.20	0.28	0.28	0.14	0.00	0.14	0.00	0.14	0.00	0.00
salivary acinar cells, donor3	11773-123I9	0.66	0.00	0.00	0.66	0.00	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	17.73	8.58	21.73	7.44	2.86	0.57	1.14	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	5.82	0.67	1.77	0.67	1.26	0.84	0.08	0.25	0.00	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	5.29	1.18	2.23	0.35	0.71	0.59	0.00	0.24	0.00	0.12
seminal vesicle, adult	10201-103F3	37.56	4.23	26.98	1.59	5.29	0.53	0.00	0.53	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	36.20	18.22	14.33	3.89	10.20	2.92	0.49	0.97	0.73	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	0.50	0.00	1.26	0.00	0.00	0.25	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	2.01	0.00	1.00	0.00	0.00	1.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	236.67	133.92	22.43	39.89	27.67	9.13	3.36	2.15	2.01	2.28
signet ring carcinoma cell line:Kato III	10436-106E4	35.15	21.33	9.39	22.33	7.41	1.33	3.21	0.88	1.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	21.42	13.03	5.42	5.16	3.87	0.65	0.90	0.52	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	3.55	0.00	1.42	0.00	0.00	1.42	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	6.00	1.08	4.80	0.48	0.24	0.60	0.00	0.12	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	64.32	23.12	14.07	11.06	9.05	1.01	2.01	2.01	3.02	0.00
skin, adult, donor1	10074-102A2	0.00	6.79	6.79	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	112.99	40.40	30.93	17.67	5.05	2.52	0.00	0.63	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	197.78	188.44	27.02	132.74	29.68	4.34	16.34	2.67	1.67	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	398.42	151.30	3.78	58.63	24.59	0.95	6.30	1.58	2.52	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	533.14	67.27	28.14	18.12	29.10	3.28	1.16	3.66	1.93	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	65.60	41.87	11.70	49.45	8.90	0.49	4.94	1.98	4.78	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	108.25	16.73	4.02	5.15	2.41	0.16	0.00	0.64	0.32	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	296.80	202.88	102.64	122.03	34.21	9.81	16.78	5.88	2.83	2.62
small intestine, adult, pool1	10024-101D6	94.60	52.55	27.35	20.19	11.82	8.48	2.03	0.96	5.73	0.84
small intestine, fetal, donor1	10064-101I1	89.19	41.03	31.69	12.53	6.63	1.72	2.46	2.21	0.49	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	191.31	69.75	89.24	58.47	28.72	40.52	1.54	2.56	5.13	12.82
smooth muscle, adult, pool1	10048-101G3	14.47	3.36	21.71	0.52	1.03	1.81	0.00	0.26	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	109.08	38.86	2.41	20.37	31.63	0.00	1.34	0.54	1.07	0.27
spinal cord - adult, donor10196	10181-103D1	7.11	0.92	5.96	0.92	1.38	0.23	0.00	0.23	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	3.55	1.58	2.76	1.18	0.79	0.00	0.00	0.00	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	6.92	1.38	4.15	2.77	1.38	1.38	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	109.77	47.57	25.61	14.03	9.76	1.22	1.22	1.22	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	9.18	2.30	4.59	1.84	0.92	0.00	0.00	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	23.30	10.45	4.93	1.19	2.09	0.90	0.15	0.30	0.45	0.15
spleen, adult, pool1	10025-101D7	13.77	3.74	8.59	0.66	2.20	1.43	0.00	0.22	0.00	0.44
spleen, fetal, pool1	10044-101F8	39.01	17.16	24.23	2.70	8.18	1.91	0.40	1.03	0.56	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	148.86	90.19	49.94	26.39	9.49	17.66	1.90	4.94	2.47	2.47
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	74.43	35.99	16.07	38.79	5.94	3.15	4.54	4.19	2.10	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.28	5.47	2.35	0.39	0.78	0.00	0.39	0.78	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.05	6.30	10.69	3.83	1.35	1.80	1.24	1.01	0.68	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	41.94	22.45	11.44	55.49	17.37	4.66	0.85	0.00	1.69	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	36.38	11.42	7.62	3.38	13.12	0.42	0.00	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	89.71	36.31	40.58	11.75	4.27	1.07	1.07	1.07	0.00	2.14
submaxillary gland, adult	10202-103F4	17.66	6.27	14.24	2.85	1.14	1.71	0.00	0.00	2.28	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	3.12	2.28	4.36	0.42	0.00	0.83	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	1.55	0.00	1.55	3.10	0.52	1.03	1.03	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	4.24	0.71	0.71	2.12	0.00	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	414.28	75.66	23.39	30.49	50.21	1.83	2.52	1.60	2.29	1.15
temporal lobe, adult, pool1	10031-101E4	4.83	2.88	4.15	1.36	0.34	0.59	0.17	0.25	0.25	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	71.23	27.78	14.96	14.96	0.71	0.71	4.27	1.42	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	43.95	10.55	23.74	14.50	5.27	0.44	2.20	1.32	0.00	0.44
tenocyte, donor1	11763-123H8	75.41	17.80	17.46	4.89	5.24	5.59	0.00	1.40	1.40	1.05
tenocyte, donor2	11765-123I1	78.59	19.84	37.39	8.01	8.39	9.16	1.53	2.29	1.53	1.53
tenocyte, donor3	11768-123I4	21.50	4.08	12.97	2.22	3.71	4.08	0.00	1.11	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	166.73	142.26	35.69	132.40	23.62	4.08	19.38	1.70	1.70	3.23
teratocarcinoma cell line:NCR-G1	10798-110I6	196.23	102.35	148.91	19.73	4.01	2.31	2.31	1.54	1.23	3.85
teratocarcinoma cell line:PA-1	10807-111A6	117.16	76.25	8.52	70.98	16.43	1.08	9.14	0.15	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	71.73	88.23	7.36	60.30	26.66	9.14	9.14	1.65	2.41	4.57
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	39.33	32.14	6.43	60.51	16.64	4.92	9.83	0.00	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	33.48	26.39	2.07	19.52	8.94	0.87	1.64	0.22	0.33	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	58.30	99.01	17.26	68.72	20.52	7.17	13.03	2.61	0.98	3.26
testis, adult, pool1	10026-101D8	14.60	3.54	19.97	0.86	0.97	1.29	0.21	0.54	0.54	0.11
testis, adult, pool2	10096-102C6	13.08	2.26	5.86	0.90	0.90	0.45	0.00	2.26	0.00	0.00
thalamus - adult, donor10196	10168-103B6	1.10	0.00	4.42	1.10	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	3.44	0.78	2.19	0.78	0.31	0.31	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	0.00	0.00	4.62	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.64	0.99	1.32	1.65	0.16	0.16	0.16	0.16	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	2.30	1.15	0.00	1.15	0.58	0.00	0.58	0.00	0.00	0.58
throat, adult	10209-103G2	11.73	5.99	11.98	4.74	2.00	2.75	0.75	0.25	0.50	0.75
throat, fetal, donor1	10061-101H7	98.42	29.86	17.98	5.79	4.88	1.52	0.30	0.30	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	79.89	15.30	2.19	16.69	35.97	0.00	1.19	0.79	1.19	0.00
thymus, adult, pool1	10027-101D9	31.51	17.89	8.75	2.39	11.33	0.99	0.70	0.80	0.50	0.40
thymus, fetal, pool1	10043-101F7	32.21	15.38	11.01	2.49	7.59	1.45	0.42	1.14	0.31	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	52.79	12.76	8.51	6.65	9.04	3.06	0.93	0.93	0.66	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	57.55	28.36	17.04	5.87	6.43	0.98	1.12	1.54	0.56	0.00
thyroid, adult, pool1	10028-101E1	3.92	0.84	8.77	0.28	0.37	0.84	0.00	0.75	0.19	0.19
thyroid, fetal, donor1	10060-101H6	29.27	7.38	6.59	1.05	0.79	0.26	0.53	0.26	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	0.00	9.24	0.00	0.00	0.00	0.00	0.00	6.16	0.00
tongue, adult	10203-103F5	4.19	1.63	5.12	0.47	0.93	0.93	0.00	0.70	0.23	0.00
tongue, fetal, donor1	10059-101H5	23.65	5.52	7.88	1.97	1.58	0.39	0.00	2.36	0.00	0.00
tonsil, adult, pool1	10047-101G2	17.33	6.11	13.72	3.91	1.90	1.90	0.50	0.70	0.30	0.20
trachea, adult, pool1	10029-101E2	16.93	9.73	20.04	7.20	3.60	2.21	0.65	1.31	1.55	0.74
trachea, fetal, donor1	10058-101H4	68.48	23.08	28.85	7.69	7.31	0.38	0.38	1.54	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.59	7.09	3.19	2.13	2.83	0.35	0.00	1.77	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	289.36	120.77	51.98	55.01	11.55	11.96	5.88	2.94	2.63	3.75
transitional-cell carcinoma cell line:JMSU1	10492-107B6	96.68	35.88	11.28	7.36	5.95	3.45	1.25	0.47	0.47	0.94
tridermal teratoma cell line:HGRT	10694-109G1	209.28	38.05	15.22	9.51	17.12	1.90	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	82.87	41.56	12.61	13.71	23.79	2.62	1.27	1.52	0.59	0.34
umbilical cord, fetal, donor1	10057-101H3	56.34	18.78	37.56	2.09	4.17	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	46.41	17.06	73.03	10.75	9.38	2.90	1.19	1.37	0.51	1.02
uterus, fetal, donor1	10055-101H1	302.55	134.64	99.83	31.74	16.38	2.05	4.61	3.07	1.54	1.02
vagina, adult	10204-103F6	5.82	0.00	10.99	0.00	0.65	2.58	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	18.63	5.26	13.59	0.66	1.75	2.19	0.00	0.00	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27